The QualityStocks Daily Thursday, May 26th, 2022

Today's Top 3 Investment Newsletters

QualityStocks(CRTD) $1.2800 +58.46%

Schaeffer's(BZUN) $9.9000 +25.48%

StocksEarning(DLTR) $162.8000 +21.87%

The QualityStocks Daily Stock List

OpGen (OPGN)

StockMarketWatch, MarketClub Analysis, BUYINS.NET, MarketBeat, QualityStocks, Marketbeat.com, PennyStockScholar, InvestorPlace, OTCtipReporter, Penny Pick Finders, PennyStockProphet, Profitable Trader Authority, StockOodles, StreetInsider, TraderPower, Pennybuster, Trades Of The Day, StockOnion, Street Insider, Money Morning, The Street, TopPennyStockMovers, Investing Lab, INO Market Report and HotOTC reported earlier on OpGen (OPGN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

OpGen Inc. (NASDAQ: OPGN) (FRA: 65O2) is a precision medicine firm that is focused on the development of molecular information services and products. The firm serves consumers in the United States as well as internationally.

OpGen Inc. is based in Gaithersburg, Maryland as was founded on January 22, 2001. The firm has a collaboration with the New York State Department of Health for developing a solution to detect, trace and manage antimicrobial-resistant infections in healthcare facilities.

OpGen Inc. uses molecular informatics and diagnostics to help fight infectious ailments. This is in addition to improving patient outcomes, helping clinicians with information on various life threatening diseases and reducing the spread of infections that are brought about by microorganisms which are multidrug-resistant.

OpGen Inc.’s product candidates include a vitro diagnostic test used to detect and identify different bacterial nucleic acids and genetic determinants of antimicrobial resistance in bacterial colonies separated from body sites or antimicrobial resistance in urine specimens dubbed the Acuitas AMR Gene Panel. Other products include PNA FISH and QuickFISH products. These diagnostic tests have been designed to detect infectious agents in positive blood cultures and have the tests have already been cleared by the FDA. Additionally, the firm provides Acuitas Lighthouse informatics systems, which merge hospital and patient information with clinical laboratory test results as well as offer insights and analytics that allow better management of multidrug resistant organisms in the patient care and hospital environment.

OpGen Inc. recently announced that it had received regulatory approval for its Curetis Unyvero System from the Chinese authorities. This move will allow the firm to market its product in China, which will help the firm grow as it extends its roots in the new market.

OpGen (OPGN), closed Thursday's trading session at $0.4802, up 27.2053%, on 2,174,406 volume. The average volume for the last 3 months is 2.125M and the stock's 52-week low/high is $0.31/$3.72.

Quotient (QTNT)

TraderPower, StockMarketWatch, Marketbeat, MarketClub Analysis, Barchart, BUYINS.NET, Marketbeat.com, QualityStocks, Trading Concepts, InvestorsUnderground, Investing Futures, Daily Trade Alert and Daily Market Beat reported earlier on Quotient (QTNT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Quotient Ltd. (NASDAQ: QTNT) (FRA: U4W) is a commercial-stage diagnostics firm that is engaged in the development, manufacture and sale of transfusion diagnostic products which focus on serological disease screening and blood grouping in Japan, France, the United States and also, internationally.

The company has its headquarters in Eysins, Switzerland and was incorporated in 2007. It operates in Newton, Pennsylvania; Eysins, Switzerland, Scotland and Edinburgh but derives most of its revenue from the United States.

The firm sells its products to blood banking operations, original equipment manufacturers, independent testing laboratories, donor collection agencies, hospital and other diagnostics firms. Its product portfolio includes specialty kits, specialty products, Antisera and red cell reagents.

The enterprise has developed a proprietary technology platform that offers tests for serological and immunohematology disease screening, dubbed MosaiQ. The company’s standard reagent products for blood grouping include ancillary products that support blood grouping; whole blood control products indicated for daily quality assurance tests; reagent red blood cells which allow blood group antibodies to be identified and antisera products that are utilized in the identification of blood group antigens. The company is also developing a SARS-CoV-2 antibody test, which is micro-array based and will be used on the MosaiQ platform for coronavirus.

The company recently won a Red Dot Product Design Award for its MosaiQ system, which has been designed to deliver rapid molecular, serological and immunohematology disease screening. The award stands as a testament to the company’s design and creativity efforts and shows just how much of an impact the company has made in transfusion diagnostics. Additionally, the firm’s MosaiQ Covid-19 Antibody Microarray recently received the FDA’s emergency use authorization. These moves by the firm are bound to bring in more investors, which will not only help push their stock prices higher but also boost their growth.

Quotient (QTNT), closed Thursday's trading session at $0.3536, up 25.6128%, on 1,238,967 volume. The average volume for the last 3 months is 1.239M and the stock's 52-week low/high is $0.2721/$4.526.

Creatd (CRTD)

QualityStocks, NetworkNewsWire, SmallCapRelations, Tip.us, MissionIR, Stocks to Buy Now, InvestorBrandNetwork, SeriousTraders, StocksToBuyNow, MarketClub Analysis, Small Cap Firm, Fierce Analyst, AwesomeStocks, StockWireNews, Broad Street, Trades Of The Day, Schaeffer's, MarketBeat, InvestorPlace, StreetInsider and BUYINS.NET reported earlier on Creatd (CRTD), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Creatd Inc. (NASDAQ: CRTD) is a technology firm that is engaged in the developing digital communities, e-commerce opportunities and marketing branded digital content.

The firm is based in Fort Lee, New Jersey and was incorporated in 1999, on December 30th by Rick Schwartz and Jeremy Phillip Frommer. Before changing its name in September 2020, the firm was known as Jerrick Media Holdings Inc. It generates revenues in the form of affiliate sales, branded content, creator subscriptions and managed services.

The enterprise has 3 platforms, i.e. Recreatd, Creatd Partners and Vocal Ventures. Its primary technology platform Vocal offers creators, podcasters and bloggers, curated and safe communities and storytelling tools, as well as opportunities to monetize their content. It also allows them to partner with brands that want to reach their audiences as well as connect with their ideal audiences.

The company provides an in-house marketing agency for e-commerce and direct-to-consumer clients, which offers performance marketing and management services, called Seller’s Choice. This is in addition to providing Recreatd, which holds legacy media assets and intellectual property, including media memorabilia, photographs and acquired artwork, to reactivate e-commerce properties and archival media assets.

The firm recently released their 2020 financial results, which show that not only did the sales, marketing and business development efforts expand, their net revenue tripled. With tactical position efforts underway to boost revenue projections even higher and new investment partners currently in development, the firm has a lot of good things in store for its stakeholders, it seems.

Creatd (CRTD), closed Thursday's trading session at $1.28, up 58.4551%, on 29,282,549 volume. The average volume for the last 3 months is 29.283M and the stock's 52-week low/high is $0.62/$9.80.

Aprea Therapeutics (APRE)

MarketClub Analysis, PennyStocks24, MyBestStockAlerts, Actual Gains, MarketBeat, The Stock Psycho, Stock Roach, Top Gun, Mina Mar Marketing Group, InvestorSoup, Penny Picks, Penny Stock Newsletter, Penny Stocks Finder, PennyPickAlerts, Hot Stock Profits, Trades Of The Day, Honest Abe, OtcShortReport, Greenbackers, Fortune Stock Alerts, Fast Moving Stocks, Damn Good Penny Picks, Stock Preacher, BUYINS.NET, Beacon Equity Research, PennyStockRumors.net, FeedBlitz, HotStockProfits, Club Penny Stocks Network, Center Stage Stocks, Market Wrap Daily, MarketWireStocks, MicroStockProfit, OTC Stock Review, PennyStockProfessor, Pennystocktweeters.com, PREPUMP STOCKS, QualityStocks, Real Pennies, RockingPennyStocks, Stock Legends, StockHideout, Stocktamer, TooNiceStocks, TopPennyStockMovers and Orbit Stocks reported earlier on Aprea Therapeutics (APRE), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Aprea Therapeutics Inc. (NASDAQ: APRE) is a biopharmaceutical firm that is focused on the development and commercialization of cancer therapies that reactivate the mutant p53 tumor suppressor protein.

The firm has its headquarters in Boston, Massachusetts and was incorporated in 2006. It operates as part of the healthcare sector, in the biotech and pharma sub-industry and serves consumers in Sweden and the U.S.

The company’s primary shareholders include KCIF Co-Investment Fund KB, Rosetta Capital Ltd. and an investment vehicle owned by Karolinska Development AB called KDev Investments AB.

The enterprise’s p53 tumor suppressor protein responds to different forms of cellular stress and activates the transcription of genes which cause apoptosis or cell cycle arrest. Its product portfolio comprises of a p53 reactivator dubbed APR-548, which is undergoing a phase 1 dose-escalation trial for oral administration in patients suffering from myelodysplastic syndromes; and a p53 small molecule reactivator dubbed Eprenetapopt (APR-246), which is currently in late-stage clinical development for various hematologic malignancies as well as other indications. They include acute myeloid leukemia and myelodysplastic syndromes, as well as refractory/relapsed TP53 mutant chronic lymphoid leukemia, non-small cell lung cancer, bladder cancer and gastric cancer. In addition to this, the enterprise is also involved in the development of APR-017, which causes p53-mediated apoptosis by restoring p53 activity in mutant p53 cancer cell lines.

The company recently announced positive results from its trial which evaluated eprenetapopt with azacitidine in the treatment of patients with TP53 mutant acute myeloid leukemia and myelodysplastic syndromes. The success of this new treatment will not only improve patient outcomes for these diseases, which currently have limited treatment options, but also boost investments into the firm, which will have a positive impact on the company’s growth.

Aprea Therapeutics (APRE), closed Thursday's trading session at $0.805, up 21.9697%, on 1,666,953 volume. The average volume for the last 3 months is 1.639M and the stock's 52-week low/high is $0.62/$7.80.

DermTech Inc. (DMTK)

MarketBeat, StockMarketWatch, StreetInsider, MarketClub Analysis, TradersPro and The Street reported earlier on DermTech Inc. (DMTK), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

DermTech Inc. (NASDAQ: DMTK) (OTC: DMTKW) (BMV: DMTK) is a molecular diagnostic firm that is focused on the development and marketing of new non-invasive genomic tests for the diagnosis of inflammatory illnesses, skin cancer and aging-related ailments.

The firm has its headquarters in La Jolla, California and was incorporated in 1995. It operates as part of the diagnostics and research industry, under healthcare sector. The firm serves consumers in the United States.

The company provides solutions for the early detection of skin cancer and inflammatory illnesses. It generates the majority of its revenues through lab services.

The enterprise develops qPCR assays to non-invasively collect skin samples through the use of adhesive tape biopsy techniques. These assays can analyze gene targets to evaluate their level of RNA expression. It also provides a gene expression test dubbed the DermTech Melanoma test, which improves the early detection of genomic atypia, helping rule out the need to carry out a surgical biopsy of atypical lesions and melanoma. It also offers adhesive collection kits for skin samples and gene expression assays for the Th17, Th2, Th1 and IFN-gamma inflammatory pathways. The enterprise also develops cutaneous T-cell lymphoma rule-out tests and non-melanoma skin cancer diagnostic products, as well as UV damage DNA risk evaluation products. It sells its products primarily to oncology and pathology practitioners.

The company remains focused on addressing the urgent need to improve melanoma’s early detection. This will not only be useful to physicians who need to diagnose the disease but also improve chances of treatment success, which will be beneficial to patients.

DermTech Inc. (DMTK), closed Thursday's trading session at $6.54, up 1.8692%, on 713,522 volume. The average volume for the last 3 months is 713,489 and the stock's 52-week low/high is $5.68/$48.32.

SurgePays Inc. (SURG)

Wall Street Resources, SmarTrend Newsletters, SmallCapVoice, MoneyTV, StockRockandRoll, PennyStockLocks, StreetInsider, Penny Stock 101, INO.com Market Report, Penny Stock General, The Street, Shiznit Stocks, Greenbackers, OTCPicks, CRWEPicks, PennyOmega, StockHotTips, DrStockPick, CRWEWallStreet, MassiveStockProfits, Zacks, PennyToBuck, CRWEFinance, QualityStocks, BestOtc, Stockhouse, StockOodles, ChartAdvisor, Wall Street Daily, Barchart, InvestorPlace, MarketBeat, Mega Stock Alerts, Street Insider, Penny Stock 112, Penny Stock 118, AllPennyStocks, PennyStockScholar, PennyTrader, Real Pennies, Small Cap Firm, StockOnion and OTCtipReporter reported earlier on SurgePays Inc. (SURG), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

SurgePays Inc. (NASDAQ: SURG) (FRA: 9B90) is a financial technology and telecommunications firm that is engaged in the provision of services to the underbanked community.

The firm has its headquarters in Bartlett, Tennessee and was incorporated in 2006, on August 18th. It operates as part of the software-application industry, under the technology sector. The firm serves consumers in the United States.

The company is also focused on building a supply chain software platform to be used as an alternative to conventional wholesale supply chain distribution models. Its operating segments include the Electronic check services and TW; Surge logics; Surge blockchain and Other segments.

The enterprise’s blockchain platform uses a suite of prepaid and financial products to convert bodegas and corner stores into technology-hubs for neighborhoods that are underbanked. It also provides SMS text and voice messaging services to low-income consumers and direct retail prepaid as well as subsidized customers. The enterprise also provides subsidized mobile broadband services to consumers in Texas, Tennessee, Rhode Island, Oklahoma, Ohio, New Jersey, Nevada, Missouri, Mississippi, Maryland, Illinois, Florida, Colorado and California. In addition to this, it offers case load management, plaintiff generation and marketing business intelligence solutions. Furthermore, it operates a bilingual operations center providing the firm with database programming, IT infrastructure design, customer service, sales support, revenue assurance and software development, among other operational support services.

The firm recently announced its latest financial results, which show increases in its revenues and reductions in its net loss. It remains focused on maximizing the growth of its subscriber base, which will not only bring in additional revenues into the firm but also bolster its growth.

SurgePays Inc. (SURG), closed Thursday's trading session at $4.79, off by 0.208333%, on 97,875 volume. The average volume for the last 3 months is 97,874 and the stock's 52-week low/high is $1.76/$5.06.

Harrow Health (HROW)

MarketBeat, CNBC Breaking News, BUYINS.NET, TradersPro, StockMarketWatch, Schaeffer's and MarketClub Analysis reported earlier on Harrow Health (HROW), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Harrow Health Inc. (NASDAQ: HROW) is an ophthalmic-focused healthcare firm that specializes in developing, producing and selling medications for the treatment of a range of illnesses.

The firm has its headquarters in San Diego, California and was incorporated in January 2006 by Robert J. Krammer and Mark L. Baum. Prior to its name change in December 2018, the firm was known as Imprimis Pharmaceuticals Inc. It operates as part of the pharmaceutical and medicine manufacturing industry, under the healthcare sector. The company has twenty-three firms in its corporate family and serves consumers in the United States, with a focus on consumers in the state of California.

The company is focused on selling medications which serve unmet needs in the marketplace through deconsolidated firms and its subsidiaries. It owns royalty rights in 4 clinical-stage drug candidates which are being developed by Melt Pharmaceuticals Inc. and Surface Ophthalmics Inc. Surface Ophthalmics is focused on developing and commercializing therapies for ocular surface diseases. The company also holds non-controlling equity positions in Melt Pharmaceuticals and Surface Opthalmics.

The enterprise develops a formulation known as Dexycu, for the treatment of post-operative inflammation. It also owns an ophthalmology pharmaceutical compounding and outsourcing business known as ImprimisRx.

The company reported its recently released financial results, which show increases in its revenues and sales. It remains focused on implementing its growth plan and increasing the share of the market that it holds, which will positively influence its investments as well as its growth.

Harrow Health (HROW), closed Thursday's trading session at $6.82, up 4.9231%, on 48,194 volume. The average volume for the last 3 months is 48,194 and the stock's 52-week low/high is $5.40/$12.99.

Livevox Holdings (LVOX)

MarketBeat and Trades Of The Day reported earlier on Livevox Holdings (LVOX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Livevox Holdings, Inc. (NASDAQ: LVOX) (FRA: 4GT1) is engaged in the development and provision of cloud contact center software for businesses.

The firm has its headquarters in San Francisco, California and was incorporated in 2004, on February 25th by Larry Siegel and Louis Summe. Prior to its name change in June 2006, the firm was known as Tools For Health Inc. It operates as part of the software-infrastructure industry, under the technology sector. The firm has three companies in its corporate family and serves consumers around the globe.

The company is party to a strategic partnership agreement with Telarus. It has additional locations in Columbus, Ohio; St. Louis, Missouri; New York; Medellin, Colombia; Denver, Colorado; Bengaluru, India; and Atlanta, Georgia.

The enterprise’s products include an AI-driven speech analytics solution dubbed SpeechIQ, which promotes quality, productivity and compliance in contact centers; Workforce Optimization, which helps contact centers to manage and measure their agent workforces; and CRM, which uses unified customer profiles to facilitate and manage digital engagement. It also offers an outbound voice solution dubbed Four Cloud, which allows the management of regulatory requirements with the option of an automated and a trio of manual outbound dialing systems. The enterprise serves BPO, customer care, telecom, healthcare, teleservices, financial services and collection industries.

The company’s latest financial results demonstrate a growth in its revenues, with its CEO noting that it was focused on marching towards profitability. This will not only encourage more investments into the company but also bolster the firm’s growth.

Livevox Holdings (LVOX), closed Thursday's trading session at $2.14, off by 0.465116%, on 169,927 volume. The average volume for the last 3 months is 169,927 and the stock's 52-week low/high is $2.01/$10.39.

Lyell Immunopharma (LYEL)

MarketClub Analysis and MarketBeat reported earlier on Lyell Immunopharma (LYEL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Lyell Immunopharma Inc. (NASDAQ: LYEL) is a T cell reprogramming firm that is focused on the development of T cell therapies for a range of human illnesses.

The firm has its headquarters in South San Francisco, California and was incorporated in June 2018 by Crystal Mackall, Stan Riddell and Richard D. Klausner. It operates as part of the biotechnology industry, under the healthcare sector. The firm serves consumers around the globe.

The company develops curative cell-based immunotherapies for human illnesses, with a focus on mastering T cells in order to learn how to destroy solid tumors. It is party to a research and development collaboration and license agreement with GlaxoSmithKline, which involves the development of the NY-ESO-1 program.

The enterprise develops its therapies using the following technology platforms: Epi-R and Gen-R. Epi-R and Gen-R are both ex vivo epigenetic reprogramming technologies which can generate T cell populations and conquer T cell exhaustion, respectively. Its product pipeline is comprised of a formulation dubbed LYL845, which has been designed to target multiple solid tumors; and a T cell product candidate dubbed LYL 797, which has been developed to treat non-small cell lung cancer. The enterprise also develops its NY-ESO-1 program for a range of solid tumor indications, including synovial sarcoma.

The firm remains focused on developing and advancing its T-cell therapies which can eradicate solid tumors. The success and approval of its therapies will not only benefit patients with these tumors but also encourage more investments into the firm, which will be good for its growth.

Lyell Immunopharma (LYEL), closed Thursday's trading session at $4.09, off by 0.486618%, on 743,735 volume. The average volume for the last 3 months is 736,112 and the stock's 52-week low/high is $3.57/$19.84.

22nd Century Group Inc. (XXII)

Schaeffer's, TraderPower, Broad Street, TradersPro, PennyStocks24, BUYINS.NET, QualityStocks, Fierce Analyst, StockMarketWatch, InvestorPlace, AwesomeStocks, StockWireNews, Small Cap Firm, Pennybuster, OTCBB Journal, StocksImpossible, Ceocast News, StockStreetWire, MarketBeat, The Street, First Penny Picks, Marketbeat.com, Money Morning, StreetInsider, Promotion Stock Secrets, InvestmentHouse, Wealth Insider Alert, Daily Trade Alert, Investing Futures, Jet-Life Penny Stocks, MarketClub Analysis, Nathan Gold, Insider Financial, Wise Alerts, Top Pros' Top Picks, Stockgoodies, CFN Media Group, DreamTeamNetwork, Investing Daily, StrategicTechInvestor, SmallCapNetwork, Leading Penny Stocks, Mega Stock Alerts, Street Insider, The Online Investor, Penny Stock, Proactivecrg and Shah's Insights & Indictments reported earlier on 22nd Century Group Inc. (XXII), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

22nd Century Group (NASDAQ: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and improving health and wellness through modern plant science, today announced its appointment of John J. Miller to direct the growth and achieve the full potential of the company’s reduced nicotine tobacco business. Miller brings more than 35 years of experience in the tobacco and consumer packaged goods industries and a demonstrated ability to attain a track record of success and superior commercial results. “We are absolutely delighted to welcome John Miller to our team,” said Jim Mish, chief executive officer of 22nd Century Group. “His significant hands-on expertise and insight in strategic planning, assessing and implementing strategic partnership opportunities, and leading sales and marketing efforts will be instrumental in accelerating revenue, profit and market share growth for the company. We look forward to John’s contributions to the success of the company’s launch of VLN(R), our reduced nicotine cigarettes with 95% less nicotine than conventional cigarettes, which is the first and only modified risk tobacco product (‘MRTP’) approved by the FDA.”

To view the full press release, visit https://ibn.fm/Chpay

About 22nd Century Group Inc.

22nd Century Group is a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science. With dozens of patents allowing it to control nicotine biosynthesis in the tobacco plant, the company has developed proprietary reduced nicotine content (“RNC”) tobacco plants and cigarettes, which have become the cornerstone of the FDA’s comprehensive plan to address the widespread death and disease caused by smoking. The company received the first and only FDA MRTP authorization of a combustible cigarette in December 2021. In tobacco, hemp/cannabis, and hop plants, 22nd Century uses modern plant-breeding technologies, including genetic engineering, gene-editing and molecular breeding to deliver solutions for the life science and consumer products industries by creating new, proprietary plants with optimized alkaloid and flavonoid profiles as well as improved yields and valuable agronomic traits. For more information about the company, visit www.XXIICentury.com.

22nd Century Group Inc. (XXII), closed Thursday's trading session at $1.85, up 1.0929%, on 589,394 volume. The average volume for the last 3 months is 579,440 and the stock's 52-week low/high is $1.42/$5.25.

Cerberus Cyber Sentinel Corporation (CISO)

We reported earlier on Cerberus Cyber Sentinel Corporation (CISO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Titan CEO and headline sponsors, Class VI Partners and Wipfli LLP today announced recognition of David Jemmett, CEO and founder of Cerberus Sentinel (NASDAQ: CISO), as a 2022 Phoenix Titan 100. The Titan 100 program recognizes Phoenix’s Top 100 CEOs and C-level executives, using criteria that includes demonstrated exceptional leadership, vision and passion. Collectively, 2022 Phoenix Titan 100 companies employ upwards of 90,000 individuals and generate over $32 billion in annual revenues. This year’s honorees will be published in a limited-edition Titan 100 book and profiled exclusively online. In addition, recipients will be honored at an awards ceremony on Sept. 29 and will be provided the opportunity to interact and connect multiple times throughout the year with their fellow Titans. “The Titan 100 are shaping the future of the Phoenix business community by building a distinguished reputation that is unrivaled and preeminent in their field,” said Jaime Zawmon, president of Titan CEO. “We proudly recognize the Titan 100 for their successes and contributions. We know that they will have a profound impact that makes an extraordinary difference for their customers and clients across the nation.”

To view the full press release, visit https://ibn.fm/e8TW2

About Cerberus Cyber Sentinel Corporation

Cerberus Sentinel is a managed compliance and cybersecurity provider (“MCCP”) with its exclusive MCCP+ managed compliance and cybersecurity services plus culture program. The company is rapidly expanding by acquiring world-class cybersecurity, secured managed services, and compliance companies with top-tier talent that utilize the latest technology to create innovative solutions to protect the most demanding businesses and government organizations against continuing and emerging security threats and compliance obligations. For more information about the company, visit www.CerberusSentinel.com.

Cerberus Cyber Sentinel Corporation (CISO), closed Thursday's trading session at $5.26, up 3.1373%, on 65,800 volume. The average volume for the last 3 months is 65,800 and the stock's 52-week low/high is $2.36/$49.00.

Canaan Inc. (CAN)

MarketClub Analysis, Schaeffer's, InvestorPlace, TradersPro, StreetInsider, Stockhouse, AllPennyStocks, INO Market Report, BUYINS.NET, InvestorsUnderground, MarketBeat, QualityStocks, Stock Fortune Teller, StockMarketWatch, StocksEarning, The Online Investor, The Street, TopStockAnalysts and SmarTrend Newsletters reported earlier on Canaan Inc. (CAN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

  • Bitcoin has seen an overall decrease of 57% since November 2021 (an all-time high) and a YTD decrease of 37%
  • Investor Mark Cuban tweeted that he believes cryptocurrency is in a lull period, much like the early internet, and expects the industry to bounce back – especially for those utilizing smart contracts for business productivity and profitability
  • Political and economically driven, green energy initiatives for mining Bitcoin and other cryptocurrencies are rising – companies like Canaan Inc. have already begun implementing the necessary changes to strive for carbon-free emissions
  • With blockchain fees high, Robinhood has created a new Web 3.0 wallet, which it plans to have available by the end of 2022 to customers, specifically designed to absolve the fees, making it a free wallet to use – one of the first of its kind
  • Despite reaching an all-time high in November 2021, Bitcoin and other cryptocurrencies have seen major shifts in value almost daily in recent weeks. According to analysts and market experts, there is a long way to go before recovery from the current crash starts.

    “While BTC’s price indicates that we’ve still got a long way to go before a rally or an early recovery, data from glassnode showed that addresses with at least 0.01 BTC passed the 10 million mark for the first time. While we already know that institutions made large BTC bets last year, this metric indicates that retail investors are continuing to remain bullish about the digital asset,” said Darshan Bathija, CEO and co-founder of cryptocurrency exchange Vauld (https://ccw.fm/hQLVt). 

    Other industry investors believe that cryptocurrency is just experiencing a ‘lull’ and will bounce back bigger and better than ever. Bitcoin has seen a decrease of 37% YTD (57% over the highest reported value in 2021), but investor Mark Cuban tweeted, “Crypto is going through the lull that the internet went through. After the initial surge of exciting apps, NFTs, DeFi, P2E, we saw the imitation phase as chains subsidized the movement of those apps to their chains (ala bandwidth and storage subsidies by startups in the 2000s).” Cuban also believes that the investors who choose smart contracts to improve business productivity and profitability will be those that win big (https://ccw.fm/v5MiY).

    A smart direction cryptocurrency investors could be heading in is the implementation of clean energy initiatives in the mining sector, with more companies focused on this green approach as a result of political, social and economic pressures to reduce the carbon footprint of crypto mining. Companies such as Canaan Inc. (NASDAQ: CAN), a developer of supercomputing chips and digital blockchain equipment, are answering the call, making it ever clearer that the future of Bitcoin is linked to green energy.

    Based in China, Canaan is world-renowned for the invention of the first ever application-specific integrated circuit (“ASIC”)-powered Bitcoin mining machine in 2013, which was one of the catalysts of the mining sector’s subsequent growth. As part of its commitment to lowering energy requirements for mining, the company released the world’s first 7nm ASIC chip in 2018, thus offering energy-efficient computing technology to the industry. Canaan remains dedicated to expanding its suite of advanced technologies to further lower cryptocurrency mining energy needs and propel the industry toward sustained growth.

    Another technological advancement that can help drive industry growth and serve as a boon for investors relates to changes in blockchain infrastructure designed to enable faster, more affordable transactions and ultimately attract a higher number of users. 

    From Bitcoin’s Lightning Network to Robinhood’s new Web 3.0 wallet with no fees, the blockchain infrastructure is constantly changing. The basic blockchain transaction is slow and costly, which has required new technology overlays to both speed up and make the process more inexpensive, especially as the acceptance of cryptocurrency as payment becomes more common. 

    “At Robinhood, we believe that crypto is more than just an asset class. Our web3 wallet will make it easier for everyone to hold their own keys and experience all the opportunities that the open financial system has to offer,” Robinhood CEO and co-founder Vlad Tenev stated, discussing his company’s new endeavor (https://ccw.fm/BQlYd). The company has not disclosed which blockchains the wallet will be compatible with but plans to have it operational and available to customers by the end of 2022.

    Given the projected growth of the crypto mining hardware market, from $1.49 billion in 2020 to an estimated $2.58 billion by 2028 (https://ccw.fm/KrxlN), as well as the impressive growth technologies such as the Lightning Network have seen in recent months (https://ccw.fm/aNLuj), it is safe to conclude that technological innovation remains one of the key drivers of the cryptocurrency market in general, and an essential driving force for the industry’s expected comeback and future expansion.

    For additional information on Canaan Inc., visit https://ccw.fm/AcwfV.

    Canaan Inc. (CAN), closed Thursday's trading session at $3.5, up 9.375%, on 2,934,447 volume. The average volume for the last 3 months is 2.934M and the stock's 52-week low/high is $2.56/$11.50.

    The QualityStocks Company Corner

    Odyssey Group International Inc. (OTC: ODYY)

    The QualityStocks Daily Newsletter would like to spotlight Odyssey Group International Inc. (OTC: ODYY).

    Odyssey Group International Inc. (OTC: ODYY) is a medical technology company focused on developing lifesaving medical products that offer technological and clinical advantages over current standards of care.

    The company’s portfolio of product technologies is diverse, featuring four unique medical products in development. Odyssey’s goal is to deliver superior products with enhanced clinical utility and market potential, thereby yielding a high rate of return for its shareholders and partners. It is guided by a senior management team with significant experience relating to refining technologies, building commercial systems and forging strategic partnerships.

    Product Portfolio

    Pharmaceuticals

    Odyssey has two pharmaceutical products in development:

    • PRV-002 is a novel compound for the treatment of concussion, which currently has no FDA-approved drug. In pre-clinical studies, PRV-002 has been shown to significantly improve both neuroscore and memory score following injury in rats subjected to concussion models. Importantly, the first-in-class novel neurosteroid demonstrated no drug-related toxicity in these trials.
      PRV-002 is currently being evaluated in a phase I clinical trial for the treatment of concussion, with phase II trials planned for launch in Fall 2022. Odyssey has also highlighted the potential of PRV-002 for additional indications such as Alzheimer’s disease, Parkinson’s disease, ALS and chromic traumatic encephalopathy (CTE).
    • PRV-001 is a novel compound intended to treat Niemann-Pick disease, a rare neurodegenerative-lysosomal storage disorder that affects an estimated 1 in 150,000 individuals in the U.S., demonstrating a 5x higher incidence in Middle Eastern populations.
      Odyssey expects to receive Orphan Drug designation from the FDA for PRV-001, which would accelerate its pathway to FDA approval and provide seven years of market exclusivity.

    Medical Devices

    Odyssey is also developing two medical device candidates:

    • CardioMap® is intended to provide early, non-invasive testing for heart disease. The system offers a number of potential advantages over traditional EKGs, including requiring less training to operate, offering heightened sensitivity and coming in a small and portable form factor. CardioMap is being developed for a 510(k) regulatory pathway, which requires a study to demonstrate equivalence to legacy EKG offerings.
      When approved, CardioMap is expected to be the only device in its class that has a predictive value, illustrating ‘grey’ areas where deterioration has begun but not yet led to pathology. Odyssey expects this feature to provide a powerful incentive for doctors to use the CardioMap device in end markets such as hospitals, doctors’ offices, rehabilitation centers and sports medicine practices.
    • Save-A-Life (SAL) is a patented, single-action, instantaneous, handheld, mechanical anti-choking device that creates a vacuum chamber in the mouth to dislodge throat obstructions in a matter of seconds, all without harm to the victim. The device is currently in development, with a proof of concept established.
      Odyssey believes that, once FDA-approved, its anti-choking device will quickly become the “accepted” standard and leader in the treatment of choking incidents globally. Its low-cost manufacturing and convenient portable design give SAL a competitive edge over competing devices utilizing cumbersome masks.

    Market Opportunities

    Odyssey’s varied development pipeline positions it to address a number of sizable market opportunities with significant unmet medical need. Concussions alone currently account for medical costs of roughly $10-15 billion annually in the U.S., despite the lack of a currently approved FDA drug treatment. This need is particularly apparent in the military and sports industry, where the likelihood of athlete head-injury recurrence is estimated at 75%.

    It is for this reason that, in March 2021, Odyssey announced the formation of a sports advisory board featuring well-known athletes supporting the company’s efforts to enhance public awareness of traumatic brain injuries and concussions, as well as the need for an FDA-approved therapy. Members of Odyssey’s sports advisory board include NFL Hall of Famers Kurt Warner & Brett Favre and two-time Olympic gold medalist Abby Wambach.

    With its CardioMap platform, Odyssey is targeting the global cardiac monitoring market, which was valued at $28 billion in 2021 by Insight Partners and forecast to reach $43 billion by 2028.

    Save-A-Life targets a similarly underserved market. Choking is the fourth-leading cause of death in children, and approximately 5,000 choking deaths occur each year in the U.S. While 95% of these deaths result from in-home incidents, current choking rescue devices fail to address in-home applications.

    Management Team

    Joseph Michael Redmond is the President, CEO and Chairman of Odyssey. He has over 30 years of commercial experience in medical device companies, previously serving as CEO of Parallax Health Sciences Inc., V.P. of Business Development for DxTech Inc. and V.P. of Sales and Marketing for Bioject Medical Technologies Inc. While at Bioject, Mr. Redmond helped raise over $15 million in capital, entered into several licensing and distribution deals with major biotech and pharmaceutical companies and grew the market cap of the company from under $10 million to over $400 million. He started his career at Abbott Labs and holds a B.A. from Denison University.

    Christine M. Farrell is the company’s CFO and Secretary. Prior to joining Odyssey, Ms. Farrell was Vice President of Finance for Bioject Medical Technologies Inc. She also held accounting and financial management positions with Spar-Tek Industries, a manufacturer of high quality and cutting-edge technology for the plywood industry, and Action Machinery, a seller of new and used robotic machine tools and equipment. Ms. Farrell holds a B.A. in Accounting from the University of Washington and an M.B.A. from Willamette University.

    Dr. Jacob W. Vanlandingham is Odyssey’s Head of Drug Development. Dr. Vanlandingham holds a Ph.D. in neuroscience with a molecular biology focus. He is a member of the Society for Neuroscience, American Society for Nutritional Sciences, National Neurotrauma Society, Faculty for Undergraduate Research in Neuroscience and the International Association of Medical Science Educators.

    Odyssey Group International Inc. (OTC: ODYY), closed Thursday's trading session at $0.23, off by 0.325027%, on 132,500 volume. The average volume for the last 3 months is 72,500 and the stock's 52-week low/high is $0.11/$0.8293.

    Recent News

    Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR)

    The QualityStocks Daily Newsletter would like to spotlight Energy Fuels Inc. (UUUU).

    Energy Fuels (NYSE American: UUUU) (TSX: EFR), the leading uranium producer in the United States, held the election of directors at its annual meeting of shareholders. The meeting was held virtually on May 25, 2022. During the meeting, the 10 nominees that were proposed for election by management were successfully elected. Elections were held via both proxy and electronic poll. The newly elected directors are J. Birks Bovaird, Mark S. Chalmers, Behamin Eshleman III, Ivy V. Estabrooke, Barbara A. Filas, Bruce D. Hansen, Jaqueline Herrera, Dennis L. Higgs, Robert W. Kirkwood and Alexander Morrison. All directors were elected by at least 84% of the vote. Energy Fuels supplies U3O8 to major nuclear utilities. The company also produces vanadium from certain of its projects as market conditions warrant and is ramping up to commercial production of rare earth element (“REE”) carbonate. To view the full press release, visit https://ibn.fm/CrdW9. Dr. Adrienne Hanly of the International Atomic Energy Agency stated recently at the World Nuclear Fuel Cycle conference that inventory levels for uranium fuel for nuclear utilities in the United States hadn’t hit the 2+ years recommended minimum. Hanly, who is a uranium production specialist at the agency, stated that at 16 months’ worth of uranium requirement, utilities in America had limited ability to manage a supply disruption independently. The specialist’s comments drew the attention of Duncan Craib, the CEO of Boss Energy, who admitted that the company’s inventory levels were low. Craib explained that historically, secondary uranium supplies had filled the gap in the demand for this metal, which wasn’t filled by the primary production of uranium. This resurgence of uranium may provide the needed spark to expand the operations of domestic extraction firms like Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR).

    Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR),based in Lakewood, Colorado, is the country’s largest producer of uranium and the leading conventional producer of vanadium, both designated by the U.S. government as critical minerals.

    As the leading U.S. diversified uranium miner, Energy Fuels’ uranium production portfolio stands apart in the world. Energy Fuels has more uranium production facilities, more production capacity, and more in-ground resources than any other company in the United States. In fact, the company’s assets have produced over one-third of all U.S. uranium over the past 15 years and is uniquely positioned to increase production to meet new demand.

    Energy Fuels utilizes both conventional and in-situ recovery (“ISR”) technology to produce uranium from three strategic facilities:

    • White Mesa Mill in Utah (conventional) has a licensed capacity of over 8 million pounds of U3O8 per year. The highly strategic White Mesa Mill is the only conventional uranium mill in the country and is proximate to some of the largest and highest-grade uranium mines and projects in the U.S., including the Company’s Canyon mine, La Sal Complex, Henry Mountains Complex and Roca Honda Project. White Mesa Mill provides Energy Fuels with significant production scalability as uranium demand increases. The White Mesa Mill also has other diverse businesses, including vanadium, rare earth elements (REE’s), alternate feed materials recycling and land cleanup, all described below.
    • Nichols Ranch Plant (ISR) is located in the productive Powder River Basin district of Wyoming and has a total licensed capacity of 2 million pounds of U3O8 per year. Nichols Ranch has produced 1.2 million pounds of U3O8 since commissioning in 2014, and it has significant future expansion potential from 34 fully licensed wellfields containing significant in-ground uranium resources.
    • Alta Mesa Plant (ISR) is located on over 200,000 acres of private land in Texas. The fully licensed and constructed ISR project has a total operating capacity of 1.5 million pounds of uranium per year and produced nearly 5 million pounds of U3O8 between 2005 and 2013. This low-cost production facility is currently on standby, maintained in a state of readiness to respond to expected increases in demand.

    In addition to being the largest uranium miner in the U.S., Energy Fuels’ overall portfolio also includes a pipeline of high-quality, large-scale exploration and development projects that are permitted or are in advanced stages of permitting, as well as an industry-leading U.S. NI 43-101 Mineral Resource portfolio.

    FACTOID: Energy Fuels has led industry efforts over the past two-plus years to get the U.S. government to recognize the importance of domestically produced uranium, including the 2018 – 2019 Uranium Section 232, the ongoing Nuclear Fuel Working Group and the recently announced creation of the U.S. strategic uranium reserve. The U.S. is by far the largest consumer of uranium in the world, yet we import almost all of our requirements; Energy Fuels aims to change that.

    Nuclear Market Potential

    Multiple studies in top scientific journals have shown that nuclear power is cleanest and most economical way to produce reliable electricity as worldwide demand continues to soar. Nuclear power is presently the only available and affordable low-carbon power source that can meet both current and future baseload electricity demands while simultaneously reducing air pollution and mitigating climate change. U.S. nuclear power plants currently generate nearly 20% of the nation’s electricity overall and 55% of its carbon‐free electricity and even a modest increase in electricity demand would require significant new nuclear capacity by 2025. According to the World Nuclear Association (WNA), there are currently 441 operable reactors, with another 54 units under construction and 439 in various stages of planning; in addition, the WNA has identified a potentially massive supply/demand gap through 2040 of 1 billion pounds. These factors among others are expected to significantly drive increased demand for uranium.

    Reasons Nuclear is Gaining Traction

    • Nuclear reactors emit no greenhouse gases during operation. Over their full lifetimes, they result in comparable emissions to renewable forms of energy such as wind and solar.
    • Unlike any other form of energy, the waste from nuclear energy is contained and managed securely. Used fuel is currently being safely stored for ultimate disposal or future reprocessing, and 96% of this waste can potentially be recycled.
    • Greater demand for clean electricity to power everything from homes to automobiles, reducing dependence on fossil fuels.

    No. 1 U.S. Producer of Vanadium in 2019

    Energy Fuels also produces vanadium as a byproduct of uranium production. Vanadium is designated a critical mineral, essential to the economic and national security of the United States. Energy Fuels was the largest producer of vanadium in the U.S. in 2019, and has significant high-grade, in-ground vanadium resources, as well as a separate high-purity vanadium production circuit at their White Mesa Mill, which is also the only conventional vanadium mill in the country. Crucial for use in the steel, aerospace, and chemical industries, vanadium plays a critical role in the production of high-strength and light-weight metallic alloys and demand is expected to increase across the globe.

    Energy Fuels has several fully permitted and developed standby mines containing large quantities of high-grade vanadium, along with uranium, including:

    • La Sal Complex (Utah)
    • Whirlwind Mine (Colorado/Utah)
    • Rim Mine (Colorado)

    Vanadium has also gained increased attention as a catalyst in next-generation high-capacity, “community-scale” batteries used for energy storage generated from renewable sources. Demand is only expected to grow as this market expands. With recent upgrades in its vanadium production operations, in 2019 Energy Fuels produced commercial levels of the highest purity (99.7%) vanadium in the mill’s history and can rapidly adjust production to meet volatile market conditions. Energy Fuels is one of the very few known avenues that provides investors access the vanadium market.

    Rare Earth Element (REE) Production, Alternate Feed Material Recycling, and Land Cleanup

    The White Mesa Mill also provides the company with diverse cashflow generating opportunities. Security of supply for Rare Earth Elements (REEs) supporting U.S. military and defense requirements is a major issue today. Energy Fuels has been approached by a number of entities, including the U.S. government, inquiring about the potential to process certain REEs at the mill. The White Mesa Mill is currently licensed to process certain REEs, including tantalum and niobium. And, early indications are that the mill can be utilized to produce several other REEs. The White Mesa Mill is also the only facility in North America licensed and capable of recycling alternate feed materials (AFMs). AFMs are essentially low-level waste materials that contain recoverable quantities of natural (or unenriched) uranium. The Company typically generates between $5 and $15 million per year from AFM recycling. Finally, Energy Fuels is seeking to become involved in the cleanup of legacy Cold War era uranium mines in the Four Corners region of the U.S., including on the Navajo Nation. The U.S. Environmental Protection Agency (EPA) has access to over $1.5 billion for the cleanup of just a fraction of the sites on the Navajo Nation. The White Mesa Mill is fully licensed to receive much of this material, we are one of the government’s lowest cost options, and we have the ability to recycle the material and produce usable uranium from it.

    Management Team

    Mark S. Chalmers, President and CEO
    Mark S. Chalmers is the president and chief executive officer of Energy Fuels, a position he has held since Feb. 1, 2018, following his role as chief operating officer of Energy Fuels from July 1, 2016 – Jan. 31, 2018. From 2011 to 2015, Chalmers served as executive general manager of Production for Paladin Energy Ltd., a uranium producer with assets in Australia and Africa, including the Langer Heinrich and Kayelekera mines where, as head of operations, he oversaw sustained, significant increases in production while reducing operating costs. He also possesses extensive experience in in situ recovery (“ISR”) uranium production, including management of the Beverley Uranium Mine owned by General Atomics (Australia), and the Highland mine owned by Cameco Corporation (USA). Chalmers has also consulted to several of the largest players in the uranium supply sector, including BHP Billiton, Rio Tinto, and Marubeni, and until recently served as the chair of the Australian Uranium Council, a position he held for 10 years. Chalmers is a registered professional engineer and holds a Bachelor of Science in Mining Engineering from the University of Arizona.

    W. Paul Goranson, COO
    W. Paul Goranson is the chief operating officer for Energy Fuels. Goranson has 30 years of mining, processing and regulatory experience in the uranium extraction industry that includes both conventional and in-situ recovery (“ISR”) mining, and he is a registered professional engineer. Prior to the acquisition by Energy Fuels of Uranerz Energy Corporation, Goranson served as president, chief operating officer and director for Uranerz, where he was responsible for operations of the Nichols Ranch ISR Uranium Project. In addition to those duties, he also managed uranium marketing, regulatory and government affairs, exploration and land. Prior to joining Uranerz, Goranson served as president of Cameco Resources, where he led the operations at the Smith Ranch-Highland, Crow Butte and North Butte ISR uranium recovery facilities. Goranson also served as vice president of Mesteña Uranium LLC, and he has served in senior positions with Rio Algom Mining, (a subsidiary of BHP Billiton), and Uranium Resource Inc. Goranson has a Bachelor of Science in Natural Gas Engineering from Texas A&I University, and a Master of Science in Environmental Engineering from Texas A&M University-Kingsville.

    David C. Frydenlund, CFO, General Counsel, Corporate Secretary
    David C. Frydenlund is chief financial officer, general counsel, and corporate secretary of Energy Fuels. His responsibilities include oversight of all legal matters relating to the company’s activities. His expertise extends to NRC, EPA, state and federal regulatory and environmental laws and regulations. From 1997 to 2012, Frydenlund was vice president of regulatory affairs, general counsel and corporate secretary of Denison Mines Corp., and its predecessor International Uranium Corporation (“IUC”). He also served as a director of IUC from 1997 to 2006 and CFO of IUC from 2000 to 2005. From 1996 to 1997, Frydenlund was vice president of the Lundin Group of international public mining and oil and gas companies, and prior thereto was a partner with the Vancouver law firm of Ladner Downs (now Borden Ladner Gervais) where his practice focused on corporate, securities and international mining transactions law. Frydenlund holds a bachelor’s degree in business and economics from Simon Fraser University, a master’s degree in economics and finance from the University of Chicago and a law degree from the University of Toronto.

    Curtis H. Moore, Vice President of Marketing and Corporate Development
    Curtis H. Moore is the vice president of Marketing and Corporate Development for Energy Fuels. He oversees product marketing for Energy Fuels, and is closely involved in mergers & acquisitions, investor relations, public relations, and corporate legal. He has been with Energy Fuels for over 12 years, holding various roles of increasing responsibility. Prior to joining Energy Fuels, Moore worked in multi-family real estate development, government relations and public affairs, production homebuilding, and private law practice. Moore is a licensed attorney in the State of Colorado. He holds Juris Doctor and MBA degrees from the University of Colorado at Boulder, and a Bachelor of Arts dual degree in Economics-Government from Claremont McKenna College in Claremont, California.

    Energy Fuels Inc. (UUUU), closed Thursday's trading session at $6.5, up 4%, on 3,547,543 volume. The average volume for the last 3 months is 3.53M and the stock's 52-week low/high is $4.32/$11.39.

    Recent News

    GreenBox POS (NASDAQ: GBOX)

    The QualityStocks Daily Newsletter would like to spotlight GreenBox POS (NASDAQ: GBOX).

    GreenBox (NASDAQ: GBOX), an innovative blockchain ledger fintech company, views acquisitions as a vital part of its growth strategy. Chairman Ben Errez notes that acquisitions allow the company to “Purchase merchant portfolios, adding processing volume to our platform, and provide a way to obtain key licensing assets, both domestically and globally, that enable us to branch out and service more verticals and geographic locations.” According to a recent article, GreenBox closed an asset purchase agreement with Sky Financial & Intelligence to acquire a portfolio of merchant accounts that contributed over $1 billion to the company’s total processing volume of about $2 billion for the full year 2021. “The acquisition of the substantial Sky portfolios is yet another stride forward for us and accomplishes two very important things,” commented Errez. “[First,] by bringing a large merchant account portfolio in-house, we eliminate the cost previously incurred from commissions and amplify our margin profile. Second, it allows GreenBox to own these customer relationships, securing a considerable portion of our processing volume base with the bonus of being able to offer additional revenue-generating solutions.” To view the full article, visit https://ccw.fm/TYWRL

    GreenBox POS (NASDAQ: GBOX) is an emerging financial technology company leveraging proprietary security and token technology to build customized payment solutions for business. The company’s mission is to build compliant, cutting-edge blockchain ledger tokenized solutions for the diverse, evolving and dynamic global market.

    GreenBox applications enable an end-to-end suite of turnkey financial products which offer improved fraud detection and better handling efficiency of large-scale commercial payment processing volumes for its merchant clients globally. The company’s proprietary blockchain and smart contract token technologies create seamless payment processing using digital encryption keys.

    GreenBox is a unified platform providing scalability for businesses to accept payments, transact, send, settle and convert in a single versatile ecosystem. GreenBox operates a private and proprietary blockchain-based payment platform that offers distinct advantages when compared to traditional payment technologies, including greater security and data privacy, as well as enhanced identity theft protection and quick settlement.

    As the settlement engine for financial transactions, GreenBox’s blockchain technology is a distributed ledger that uses digitally encrypted keys to verify, secure and record details of each transaction conducted within GreenBox’s private ecosystem. The speed and security of the platform allows GreenBox to log immense volumes of immutable transactional records in real time for Tier-1 partners around the world.

    In November 2021, GreenBox announced the closing of a previously announced $100 million convertible note financing. The company plans to use proceeds for acquisitions, a planned stablecoin spin-off, and additional working capital toward the company’s future growth. The initial conversion price equals a more than 80 percent premium to the market price of the company’s common stock on October 29, 2021, and values the enterprise at more than $700 million upon conversion.

    Brands & Solutions

    The company offers multiple solutions and brands under the GreenBox label. The other brands that are nested under the GreenBox POS label include coyni, ChargeSavvy, QuickCard, Transact Europe [didn’t yet close] and Northeast Merchant Systems. Each of these brands play a large role in allowing GreenBox to accel in customizing payment solutions across different verticals and industries.

    Payment Solutions

    The GreenBox platform offers blockchain secure, robust payment processing solutions for both individual consumers and businesses. The company combines the power and security of blockchain with bank-level tools necessary to both settle transactions and monitor cash flows. Customers can transfer cryptocurrencies like USDC, Ethereum or Bitcoin from external decentralized crypto wallets to their GreenBox wallets. They can also exchange those tokens from their GreenBox wallets to any supported coin. Customers can easily offload in USDC to a debit card or a multitude of gift cards.

    White Label Solutions

    The company’s white label platform allows it to partner with firms seeking blockchain-based tools to manage merchant relationships. White label partners can monitor cash flows, as well as run reports on merchant transactions, chargebacks, agent and affiliate commissions and more. Partners can access the platform through their partner portal to manage business relationships with full visibility. The platform’s cutting-edge technology saves partners time and simplifies their payment processing. It ensures compliance with automated Know Your Customer and Know Your Bank services and allows customers to set up automated payouts.

    coyni Stablecoin

    The company is planning soon to launch its own stablecoin, coyni (CYN). coyni is equivalent to the value of the U.S. dollar on a one-to-one ratio. Stablecoin allows for instantaneous transactions with blockchain security just like other cryptocurrency tokens, but without the price volatility of traditional cryptocurrencies. The CYN token is expected to make possible features like digital dollar accounts, cross border payments, international payment processing and other payment solutions. As a smart contract technology, coyni will offer instant settlement using the GreenBox blockchain ledger in any location and currency – crypto or fiat – all at lower fees and in a tokenized secure ecosystem.

    Market Overview

    A Mordor Intelligence report put the transaction value of the global digital payments market at $5.44 trillion in 2020 and projects the market to be worth $11.29 trillion by 2026. That represents a CAGR of 11.21 percent during the period of 2021-2026.

    The report notes that the global COVID-19 pandemic and its impact on e-commerce is likely to encourage strengthened international cooperation and further development of policies for online purchasing and supply. The report states, “The pandemic has made it clear that e-commerce can be an important tool/solution, especially considering the fact that e-commerce sales can support small and medium businesses that form the backbone for certain economies. This is expected to substantially spur the growth of digital payment methods across various economies.”

    According to Mordor, other drivers of the growth trend in digital payments include:

    • Greater convenience, favorable government policies and evolving consumer behavior worldwide
    • Rapid rise in smartphone penetration throughout emerging economies
    • Introduction of mobile wallets across the world
    • Widespread adoption of retail digital payment services across the vast population of China, serving as a kind of test case for other countries

    Management Team

    Ben Errez, Chairman of the Board of Directors

    Ben Errez’s past positions have included positions at large companies like Microsoft and Intel. He has brought this expertise to lead GreenBox into the forefront of the blockchain-based financial software, services, and hardware market.

    Mr. Errez was one of the early managers of Microsoft in 1991. From 1991 to 2004, he served as Software Development Lead for the Microsoft International Office Group. He led the International Microsoft Office Components team (Word, Excel, PowerPoint) in design, engineering, development, and successful deployment. He also served as Executive Representative of Microsoft Office and was a founding member of the Microsoft Trustworthy Computing Team both within the company and internationally. Mr. Errez co-authored the first Microsoft Trustworthy Computing Paper on Reliability. At Microsoft, he was responsible for the development of the first Microsoft software translation Software Development Kit (“SDK”) in Hebrew, Arabic, Thai, and Simplified Chinese, as well as the development of the first bidirectional extensions to Rich Text Format (“RTF”) file format and all bidirectional extensions in text converters for Microsoft Office. He also contributed to the development of the international extensions to the Unicode standard to include bidirectional requirements under the World Wide Web Consortium (“W3C”).

    In 2004, Mr. Errez transitioned into the world of consulting, where he held the position of Principal Consultant from founding to the present date, through which he advises clients in the South Pacific region with market capitalizations ranging from $50 million to $150 million on commerce, security, reliability, and privacy.

    In 2017, immediately before partnering with Fredi Nisan to launch GreenBox, Mr. Errez was asked to take over the Microsoft Alumni Network for the Southern California region as a regional director. Mr. Errez has been a principal of GreenBox since its inception in 2017.

    Fredi Nisan, Chief Executive Officer

    Fredi Nisan’s career in technology began during his years of service in the Israeli Defense Forces, where he served as IT Manager for all of Israel’s Northern Bases. After serving in the military, Mr. Nisan opened and operated a computer hardware store before becoming the Inventory Operations Manager for Zicon Israel in 2005, a hardware and software producer. At Zicon, he supervised inventory operations, worked on quality controls for motherboards and chips, and educated customers on software and hardware product functionality. Subsequently, Mr. Nisan moved to the United States, where he worked for One Coach in San Diego, California, as a business coach. One Coach specializes in customized growth solutions for small business owners, including the latest strategies for sales, internet marketing, branding, and ROI. Mr. Nisan was consistently ranked as the top salesperson for small business coaching while working with One Coach.

    In 2010, Mr. Nisan launched Brava POS, where he served as President until 2015. Brava POS provided point of sale (“POS”) systems for specialty retail companies. Mr. Nisan developed software to provide clients with solutions for issues ranging from inventory management to payroll to processing high volume transactions in the form of a cloud-based POS system. This system had the capability to manage multiple stores with centralized inventory and process sales without an internet connection, and offered a secure login for each employee, as well as including advanced inventory management and reporting, plus powerful functionality for its end users.

    In 2016, Mr. Nisan founded Firmness, LLC. Through Firmness, he created “QuickCitizen,” a software program that simplifies the onboarding process for new clients of law firms specializing in immigration issues. The QuickCitizen software significantly reduced law firms onboarding processing time from more than three hours to approximately 15 minutes. Mr. Nisan has been a principal of GreenBox since its August 2017 inception. In January 2018, Firmness sold QuickCitizen to GreenBox.

    Jacquline B. Reynolds, Chief Marketing Officer

    Jacqueline B. Reynolds is the company’s Chief Marketing Officer. She served most recently as vice president of marketing for Sprouts Farmers Market. She has built her reputation as a world-class global marketer, working with Coca-Cola, McDonald’s, Verizon, Walmart, L’Oréal, Xbox, 7-Eleven and many other Fortune 500 brands. She has managed award-winning marketing programs with partners such as the NFL, Super Bowl LIV, the Olympics, the FIFA World Cup, Sony Pictures, Universal Music and others.

    GreenBox POS (NASDAQ: GBOX), closed Thursday's trading session at $2.63, up 3.9526%, on 176,432 volume. The average volume for the last 3 months is 176,416 and the stock's 52-week low/high is $1.65/$16.50.

    Recent News

    FuelPositive Corp. (TSX.V: NHHH) (OTC: NHHHF)

    The QualityStocks Daily Newsletter would like to spotlight FuelPositive Corp. (NHHHF).

    FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF) today announced that it addressed attendees of the H.C. Wainwright Global Investment Conference held in Miami on May 25, 2022. The company’s COO Nelson Leite provided a corporate update, with FuelPositive’s containerized green ammonia production system the main focus of the presentation, as well as met with a series of registered investors. “We like these conferences because they give us an opportunity to showcase our technology and learn from investors about what matters to them. Our timing to market is the critical factor right now,” Leite said in the press release. “We continue to be on track to have our first demonstration system fully validated and ready to go by late summer, 2022. By ‘fully validated,’ we mean will have validated the purity of the green ammonia produced by the system, as well as the energy consumption, and the rate of production.” To view the full press release, visit https://ibn.fm/PLPPD

    FuelPositive Corp. (TSX.V: NHHH) (OTC: NHHHF) is a growth stage company focused on licensing, partnership and acquisition opportunities building upon various technological achievements. The company is committed to providing commercially viable and sustainable clean energy solutions, including carbon-free ammonia (NH3), for use across a broad spectrum of industries and applications.

    FuelPositive is headquartered in Toronto, Canada.

    Hydrogen Economy Problems and FuelPositive’s Carbon-Free Technology

    The hydrogen economy is currently facing many challenges. Traditional NH3 manufacturing exists on a massive scale, but centralized facilities result in some of the world’s most concentrated CO2 emissions. In total, an estimated 200 million metric tonnes of NH3 are consumed each year, with greater than 80% utilized by the agricultural sector. NH3 is also being positioned as a viable alternative to fossil fuels.

    FuelPositive’s flagship carbon-free ammonia technology provides an innovative solution to these environmental concerns. Developed by Dr. Ibrahim Dincer and his team, the company’s platform allows for the in-situ production of NH3 in an entirely sustainable manner, using only water, air and sustainable electricity.

    The production of hydrogen is energy intensive, but it is just one variable hindering the growth of the hydrogen economy. Other hurdles include:

    • Storage – The storage of hydrogen by compression or liquification are both cost prohibitive and unsustainable.
    • Distribution – The distribution network for effective hydrogen deployment has yet to be developed, as the extreme high-pressure distribution requirements to transport hydrogen would result in enormous infrastructure costs.
    • End Use – R&D on the transportation-related end use applications for hydrogen is in its infancy, but almost any vehicle on the road today can be easily converted to run on NH3 at a considerably lower cost per mile traveled when compared to traditional fossil fuels.

    A key benefit of FuelPositive’s patent-pending, first-of-its-kind carbon-free NH3 technology is its flexibility. The process allows for small, medium or large-scale production of NH3 on location, minimizing or even eliminating the challenges and volatility associated with storage and transportation to end use. As such, with an appropriately sized FuelPositive system and access to renewable energy, the end use applications for the company’s platform are nearly infinite.

    Manufacturing Partnership

    On May 19, 2021, FuelPositive announced its selection of National Compressed Air Canada Ltd. (“NCA”) to undertake manufacturing of the company’s Phase 2 hydrogen-ammonia synthesizer commercial prototype systems for carbon-free ammonia production.

    In a news release detailing the partnership, FuelPositive CEO Ian Clifford noted, “This critical milestone for FuelPositive will confirm the broad application potential for our technology and is the backbone of our Carbon-Free Hydrogen-NH3 offering. Partnering with the knowledgeable and experienced team at NCA on this commercialization project will bring our development-stage program to life.”

    Global Ammonia Market Outlook

    The global ammonia market was valued at $52.71 billion in 2017 and is forecast to reach $81.42 billion by 2025, growing at a CAGR of 5.59%, according to data from Fior Markets (https://ibn.fm/1OfOB).

    The agricultural industry consumes more than 80% of global NH3. Smaller percentages can be attributed to the waste, water treatment, refrigerants, antiseptic, textile, mining and pharmaceutical industries.

    One of the most polluting industries on the planet consists of conventional agribusinesses. These polluters are responsible for more greenhouse emissions per year than transportation. This is where FuelPositive’s technology is expected to be extremely beneficial.

    Management Team

    Ian Clifford is Director, CEO and Founder of FuelPositive Corp. He has over 25 years of experience in the fields of technology and marketing and has successfully led the company to global brand recognition through its unique energy solutions. Since 2006, Mr. Clifford has raised over $50 million in equity financing for FuelPositive. He also co-founded digIT Interactive, a full-service internet marketing company serving Fortune 500 clients, which he sold at the peak of the market in 2000.

    Greg Gooch serves as a Director and President of FuelPositive. His multifaceted career in the electronics and finance industries has positioned him as a key advisor and funding partner to start-ups and new technology companies for over 40 years. Mr. Gooch has been involved with FuelPositive since its early days and has remained a significant supporter and consultant to the company over the years. He has a bachelor’s from McGill University and an MBA from the University of Western Ontario.

    Dr. Ibrahim Dincer is a scientific advisor to FuelPositive and is recognized as a pioneer and international leader in the area of sustainable energy technologies. Along with his team, Dr. Dincer invented the modular carbon-free ammonia (NH3) production technology that FuelPositive is commercializing. His area of specialty covers various topics including ammonia, hydrogen energy and fuel cells; renewable energy systems; energy storage systems and applications; carbon capturing technologies, and integrated and hybrid energy systems He is currently managing an exemplary team of researchers in this commercialization project.

    Marek Warunkiewicz is the company’s Communications & Branding Specialist. He brings more than 40 years of entrepreneurial expertise to the FuelPositive team, having held marketing, branding, advertising, project management and graphic design positions with various companies. Mr. Warunkiewicz has successfully created business-to-business marketing and advertising campaigns for a diverse group of clients ranging from high-tech to agriculture. He co-founded digIT Interactive and ZENN Motor Company alongside Ian Clifford.

    Luna Clifford is the Director of Communications for FuelPositive. She has over 10 years of experience as a business owner and advisor, helping build and operate several successful start-up enterprises while managing complex stakeholder relationships. Ms. Clifford excels in strategic planning and team building, and she has completed extensive studies in the fields of communications and health care.

    FuelPositive Corp. (NHHHF), closed Thursday's trading session at $0.12895, up 3.0858%, on 150,723 volume. The average volume for the last 3 months is 150,723 and the stock's 52-week low/high is $0.09/$0.31.

    Recent News

    LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF)

    The QualityStocks Daily Newsletter would like to spotlight LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF).

    • LQwD released its platform as a service offering in November 2021, also releasing its first node on the Lightning Network – US-West
    • Since then, nine additional nodes have been released worldwide: Ireland, India, Germany, Indonesia, Italy, Singapore, Sweeden, England, and France – with more likely to follow
    • Despite volatility in Bitcoin, the Lightning Network continues to grow, with most recent reports indicating that the Network’s capacity is over 3,539 BTC
    • Users can send payments quickly and with lower fees when utilizing the Lightning Network and PaaS solutions like LQwD

    One of the most dependable characteristics of the cryptocurrency market is its volatility. Despite seeing an all-time high in November 2021, the current cryptocurrency market cap has lingered in the US $1.24 to US $1.31 trillion range struggling to break beyond this limited barrier. On May 24, 2022, the closing price of Bitcoin again fell below US $30,000 – dropping more than 3% in 24 hours. “The crypto market struggled to stay in the green as sellers dominated the market to open the week. Tether has paid $10 billion in withdrawals since the crypto market, which indicates large-scale liquidations across the crypto market by the investors to recalibrate their portfolio,” BuyUcoin CEO Shivam Thakral stated (https://ccw.fm/uBVEC). “The crypto market is expected to stay in a bear phase for some time, and most the investors will stay in a wait and watch mode.” Not all companies are in the “watch and wait” mode when it comes to Bitcoin or the Lightning Network. LQwD FinTech (TSX.V: LQWD) (OTCQB: LQWDF), a financial technology company focused on creating enterprise-grade infrastructure to drive bitcoin adoption, is still leveraging the Lightning Network with its platform as a service (“PaaS”). LQwD launched its PaaS offering lqwd.tech in November 2021, the same time it launched its first node on the Lightning Network in the United States. Since then, LQwD has strategically launched nine additional nodes worldwide in Ireland, India, Germany, Indonesia, Italy, Singapore, Sweden, England, and France. LQwD FinTech (TSX.V: LQWD) (OTCQB: LQWDF), a company focused on developing institution-grade payment infrastructure, liquidity and solutions for the Lightning Network, has joined Visa’s Fintech Fast Track Program. The program “was established for fintech companies to create new and innovative payment solutions through partnership, collaboration and investment. It offers companies a payments path that is right for their current endeavors – including the idea, funding and growth stages. Visa provides these companies with startup incentives, faster onboarding, and dedicated expertise and support,” explains a recent article. “By working with Visa, a world leader in digital payments, LQwD can accelerate bringing Bitcoin to the masses through its subsidiary Coincurve.com, a virtual currency platform, along with its proprietary platform-as-a-service (‘PaaS’) offering and global routing nodes… Shone Anstey, CEO of LQwD, underlined this as an exciting opportunity for the company. ‘Our direct relationship with Visa now gives LQwD the advantage of accessing their growing partner network, as well as experts in the payments space. It’s a big benefit.’” To view the full article, visit https://ccw.fm/Yy6lX

    LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) is a financial technology company focused on creating enterprise-grade infrastructure to drive bitcoin adoption.

    LQwD FinTech’s mission is to develop institutional-grade services that support the Lightning Network and drive improved functionality, transaction capability, user adoption and utility, and scaling of bitcoin. LQwD is also securing a substantial position in bitcoin as an operating asset and will use its holdings to establish nodes and payment channels on the Lightning Network.

    The Lightning Network is a second-layer protocol, sitting above the bitcoin blockchain, intended to facilitate faster micro-transactions and lower fees on bitcoin transactions, thus allowing mass adoption of bitcoin.

    LQwD expects the Lightning Network to eclipse the patchwork of legacy financial networks that are used to move value today. The company’s software will make migration from legacy networks onto the Lightning Network easy and seamless. By onboarding more financial service providers, LQwD intends to grow the value of the Lightning Network.

    The company, formerly known as Interlapse Technologies Corp., is harnessing new payment rails built on top of the bitcoin blockchain that are capable of beyond visa-level transaction volumes and backed by bitcoin, the strongest and most well-known cryptocurrency. These new rails, enabled by the Bitcoin Lightning Network, open a vast opportunity and market segment for digital payments and financial services on a global scale. LQwD aims to leverage its position as a public company to enhance trust in its products and services, and leverage its shares as currency for acquisitions, roll-up and growth, as well as to attract and retain top industry talent.

    Product

    The Lightning Network is a solution to massively scale the use of bitcoin for microtransactions globally, dramatically improving upon fees, as well as providing instant settlement times. The Lightning Network has experienced explosive growth and is expected to continue with the trend as usage increases. Well-known companies, such as Twitter and Square, have expressed their enthusiasm to incorporate Lightning Network into their platforms. The Lightning Network is scalable, global, open, inclusive, permissionless and decentralized. It is made up of nodes connected via payment channels, and enables off-chain, instantaneous and cheap payments at scale.

    Upon launch of LQwD’s Lightning Network platform-as-a-service, users will be able to leverage the Lightning Network infrastructure to send payments instantly, securely and inexpensively anywhere in the world. Companies and service providers will be able to conduct Lightning Network transactions in bitcoin by integrating LQwD’s infrastructure with their business or web property. Connected businesses will be able to easily deploy, monitor and manage LQwD’s Lightning Network nodes with no or low-level technical knowledge required. The company fully expects Lightning Network to be a force for global change and to become the monetary exchange network of the future.

    The Lightning Network, which is already built, functioning and growing, will advance bitcoin from a store-of-value to a global monetary network through payment utility. The company expects the Lightning Network will propel the growing number of active blockchain wallets to new heights, by increasing bitcoin’s scalability and lowering its fees for users. For coming generations, everything from wealth to experiences will be acquired and transacted virtually, and LQwD sees the Lightning Network as an enabling technology that can bring bitcoin to hundreds of millions of new users across the globe.

    Market Outlook

    Forbes in August 2021 noted that “private investors are funding companies that are building the infrastructure that will support future growth of crypto and digital assets,” and called public companies building cryptocurrency infrastructure “the hottest part of the crypto market.” While the first wave of investor interest in crypto firms was directed at companies catering to retail investors, investors have now shifted their attention to infrastructure builders, like LQwD FinTech. Forbes did not put an estimated value on the crypto infrastructure market but pointed out that large-scale adoption of cryptocurrencies will only happen when infrastructure is in place to support it. The larger digital payments market, of which crypto payments are a small fraction, is growing at more than 14 percent annually and is forecast to hit $154 billion by 2025.

    Management Team

    Shone Anstey is co-founder, chairman and CEO at LQwD FinTech. He has 20 years of experience in building complex technologies and has acted as technology lead for an industrial bitcoin mine and bitcoin mining pool. He is a Certified Cryptocurrency Investigator, and an advisor to the British Columbia Securities Commission. He is also co-founder of BIGG Digital Assets (OTCQX: BBKCF) and took that company public in 2017.

    Barry MacNeil is CFO at LQwD FinTech. He is a member of the Chartered Professional Accountants of British Columbia and has more than 30 years of management and accounting experience with public companies and in private practice. His previous positions include director of both public companies and nonprofits, as well as Chief Financial Officer and Corporate Controller.

    Albert Szmigielski is co-founder and CTO at LQwD FinTech. He was formerly the Head of Research and Chief Blockchain Engineer at Blockchain Intelligence Group and VP Research at CipherTrace. He holds a B.Sc. in Computing Science from Simon Fraser University, and a Master of Science in Digital Currencies and Blockchain Technologies from the University of Nicosia, Cyprus.

    LQwD FinTech Corp. (LQWDF), closed Thursday's trading session at $0.0975, up 1.5625%, on 8,227 volume. The average volume for the last 3 months is 8,227 and the stock's 52-week low/high is $0.0754/$0.8102.

    Recent News

    Sharing Services Global Corporation (SHRG)

    The QualityStocks Daily Newsletter would like to spotlight Sharing Services Global Corporation (SHRG).

    Sharing Services Global (OTCQB: SHRG), dedicated to maximizing shareholder value through the acquisition and development of innovative companies, understands that the ability to establish and maintain strong brand equity creates passionate and loyal customers. A recent article contains excerpts from a Direct Selling News (“DSN”) writeup that shares key tips to help companies in the direct sales space up their brand game. The piece notes that creating a community and differentiating are essential steps in building a powerful brand. “Sharing Services could be the poster child for these tips. Since inception, the company has devoted itself to creating a community where both entrepreneurs and consumers can find health, wealth and happiness. The company has created a place where entrepreneurs can succeed as they work together to serve others in a community where technology is a strength, research is the foundation to excellence in decision making, and quality is fundamental to sustainable success. The company further differentiates itself by replacing complexity with simplicity and making timely decisions,” the article reads. To view the full article, visit https://ibn.fm/T7FL5

    Sharing Services Global Corporation (SHRG), formerly Sharing Services Inc., is a diversified company dedicated to maximizing shareholder value, operating through two primary subsidiaries: Elepreneurs Holdings, a direct-selling company, and Elevacity Holdings, a products company. Headquartered in Plano, Texas, SHRG markets and distributes Elevate-branded health and wellness products through an independent sales force of distributors called Elepreneurs.

    Proprietary Products

    SHRG’s current exclusive Elevate product offerings are marketed under the Elevacity brand, so named to signify the company’s commitment to elevating lives.

    The Elevate health and wellness product line consists of nutraceutical products that SHRG refers to as D.O.S.E., which stands for dopamine, oxytocin, serotonin and endorphins – all of which are key hormones proven to promote happiness and well-being.

    Elevacity brand products are carefully formulated, chosen and designed to support a single objective: elevate the happiness and well-being of the consumer.

    Global Network of Elepreneurs

    Elevacity products are shared and sold by a growing international network of home-based entrepreneurs, called Elepreneurs, operated by Elepreneurs Holdings. This SHRG subsidiary provides basic and advanced programs for both new and experienced entrepreneurs who are focusing on their direct-sales careers.

    SHRG’s high-performing independent sales force follows the company’s Blue Ocean selling strategy, an approach that encourages individuals to seek new markets, lead, and to “stop competing and start creating.” The Blue Ocean strategy is based on the book, “Blue Ocean Strategy,” written by Professor Renée Mauborgne, who notes that “the lesson here is that the best defense is offense, and the best offense… is to make a blue ocean shift and create your own blue ocean.”

    Following this selling strategy, SHRG’s Elepreneurs are taught that, rather than competing directly in a competitive, direct-selling market, they should focus on making competitors irrelevant and succeeding in an uncontested marketplace.

    In addition, SHRG’s Elepreneurs use the interactive, video-based VERB sales-marketing platform developed by Verb Technology Company Inc. The app utilizes proprietary interactive video data collection and analysis technology and provides next-generation customer relationship management, lead generation, and video marketing software applications.

    Continued Momentum as Industry Leader

    These selling strategies have resulted in sharp and consistent revenue gains. In the company’s 10-Q filed with the SEC for the three months ended Oct. 31, 2019, SHRG reported sales of $38.8 million for fiscal Q2 2019, an increase of 116% over sales of $17.9 million reported for the comparable quarter of 2018. Consolidated gross profit jumped by $16.2 million to $27.4 million for the same period compared to Q2 2018.

    SHRG’s consolidated operating earnings were $3.9 million in the fiscal quarter ended Oct. 31, 2019, compared to $866,802 for the comparable period the prior year. Consolidated gross margin also grew 70.9% for the three months ended Oct. 31, 2019, compared to 62.2% the prior year.

    These numbers are continuing a trend established over the past two years. In fiscal Q1 2019, SHRG achieved revenues of $35.4 million, more than double that of the comparable period in 2018. Even earlier, the company reported sales of $85.9 million for fiscal year ended April 30, 2019. This represents a nine-fold increase, or $77.5 million jump, over the company’s revenues of $8.4 million the prior year.

    These numbers bring SHRG’s sales revenues since December 2017 — when the company’s Elevate product line was released — to an impressive cumulative total of $169 million.

    Preparing for Success

    SHRG is well prepared to continue and accommodate for this growth. The company recently expanded its corporate footprint by moving to a 10,000-square-foot facility in Plano, Texas, that offers ample room to expand as the company grows and flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.

    In addition, the company has a seasoned, expert leadership team in place, led by John “JT” Thatch. Thatch was appointed president and CEO of SHRG in March 2018, bringing to the company his expertise obtained from successfully starting, owning and operating several businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist SHRG as the company aims to expand and increase revenues.

    Contact
    469.304.9400 x 201
    Info@SHRGinc.com
    http://www.SHRGinc.com

    Sharing Services Global Corporation (SHRG), closed Thursday's trading session at $0.035, up 32.0755%, on 4,157 volume. The average volume for the last 3 months is 4,157 and the stock's 52-week low/high is $0.023/$0.233.

    Recent News

    AREV Life Sciences Global Corp. (CSE: AREV) (OTC: AREVF)

    The QualityStocks Daily Newsletter would like to spotlight AREV Life Sciences Global Corp. (CSE: AREV) (OTC: AREVF).

    UNICEF recently warned that the worldwide risk for child malnutrition, which was already increasing before Russia invaded Ukraine, had significantly risen. In its recent press release, UNICEF noted that 10% of children in Cambodia were actively impacted by malnutrition. The organization stated that severe wasting, which could be observed when a child was too thin for their height, is the most life threatening and visible form of malnutrition. In its Child Alert press release, the United Nations Children’s Fund estimated that globally, at least 13.5 million children aged five and below suffered from severe wasting. Many for-profit companies such as AREV Life Sciences Global Corp. (CSE: AREV) (OTC: AREVF) are focused on finding better ways to treat the different conditions that arise when malnutrition becomes severe. There is hope that when worst comes to worst and malnutrition compromises the health of people in different parts of the world, treatments will be available to address those complications.

    AREV Life Sciences Global Corp. (CSE: AREV) (OTC: AREVF) is a fully integrated, publicly traded, early-stage life science enterprise dedicated to delivering therapeutic interventions to public health through discovery, innovation and successful collaborations in the life science industry. The company’s leadership drives discovery programs for clinical complexities presented by malnutrition, viral infectious diseases and the inflammatory response system.

    AREV’s business model leverages the core competency of producing proprietary compounds through its innovative extraction methodologies, scientific advisory board (SAB), experienced staff, and executive leadership to drive its product pipeline. AREV’s strategy is to generate revenue from selling its branded products via its online technology platform, Medicine Merchant™, an enterprise marketing platform built to enable consumers to have access to novel therapeutic approaches to human nutrition, endemic diseases, and neglected chronic related co-morbidities. The company also expects to generate revenue from toll processing and government procurement of its products that address malnutrition and related health issues.

    AREV is focused on innovations in biomedicine and maintains a significant footprint in clinical human nutrition utilizing proprietary protein blends and terpenes, complimented with vitamins and minerals. The company has utilized its expertise to design and deliver innovation in therapeutic interventions using its exclusive botanical, fungi and marine compounds to address medical conditions driven by presenting global epidemiological characteristics of multiple challenges to international human and animal health. AREV uses its proprietary extractions allowing characterizations from botanical and marine sources in therapeutic foods and medicines that comprise its development pipeline.

    Development of AREV’s pipeline is fostered by collaborations with academic centers, clinical research organizations and government institutions committed to facilitating discovery of promising new clinical approaches presented in peer reviewed journals. AREV operates under the guidance of its SAB and a growing number of strategic collaborations with CROs and academic research centers, including the Linus Pauling Institute at Oregon State University.

    AREV is a member of both BIOTECanada and The Biotechnology Industry Organization (BIO):

    • BIOTECanada is the national industry association with over 200 members located nationwide, reflecting the diverse nature of Canada’s health, industrial and agricultural biotechnology sectors.
    • BIO is the world’s largest advocacy association representing member companies, state biotechnology groups, academic and research institutions, and related organizations across the United States and 30+ countries.

    Products

    AREV’s end-product and target categories include therapeutic interventions, botanical drugs, ready-to-use therapeutic food (RUTF), enteral nutrition formulas and early-stage small molecule antiviral therapeutics demonstrating novel mechanisms of action.

    Wright and Well Branded Line

    Wright and Well Branded Line is the company’s branded line of therapeutic cannabinoid and terpene-based formulations. The topical line includes solutions for burns, wounds, skin disorders and muscle relief, as well as a lubricant for intimacy. The oral line addresses inflammation, heart health, high blood pressure and viral infections. These products are currently produced at CBD99, a licensed processor in Sandy, Oregon. The company also has a strategic relationship with a Canadian licensed hemp and cannabis processor in Vancouver, British Columbia.

    SUS-TAINN™

    The company’s products in the RUTF category are branded under SUS-TAINN™ (Superior Utility Supplementation Therapeutic Agent for Indicated Nutritional Needs). SUS-TAINN™ is the flagship line of products stemming from AREV’s collaboration with Voynich Biosciences.

    RUTFs like SUS-TAINN™ are the cornerstone to international famine response and currently represent more than 20 percent of public health commodity procurement spending. SUS-TAINN™ is purchased by agencies ranging from the U.S. Department of State AID for International Development to the World Food Program and is distributed by an increasingly substantial number of non-governmental organizations.

    RESTORE™

    The company’s enteral nutrition product is branded as RESTORE™. For patients experiencing caloric compromise, enteral nutrition, a liquid form of nourishment, is often required. RESTORE™, the initial enteral formulation from AREV, is based on organic plant nutrition for patient populations who have demonstrated overt clinical need for rational enhanced caloric intake and micronutrient supplementation.

    RESTORE™ provides a proprietary blend of high-quality proteins, antioxidants, minerals and proven anabolic agents, combined with pre- and probiotics. The company plans to submit for Medicaid formulary inclusion and reimbursement designations in various jurisdictions characterized by the Ryan White CARE Act during the second half of 2022.

    REV-I1™

    REV-I1™ is the company’s small molecule drug discovery model for phytomedicinalization, based on advanced computational characterization and next generation affinity selection that affords new opportunities in HIV antiretroviral research. REV inhibition offers a critical approach to inhibiting HIV replication and addressing viremia in highly conserved sanctuary regions.

    Phytomedicinal therapeutic discovery and development offer clinically viable approaches to a wide range of scientific challenges that currently elude successful contemporary interventions. A cornucopia of diverse validated compounds allows AREV to explore a distinguished range of promising approaches that are in stages of pre-clinical validation. Combining AREV’s versatile extraction capability with highly sensitive analytical techniques (LC-MS, MS-MS) is expected to allow new medicinal chemistry to be identified and characterized, leading to therapeutic candidates in the company’s commercial drug discovery platform.

    Market Overview

    A report from Verified Market Research valued the global plant protein market at $29.4 billion in 2020 and forecast that it could surpass $162 billion by 2030, which would make up 7.7% of the global protein market, according to a report released in August by Bloomberg Intelligence.

    The RUTF market was valued at $363.72 million in 2019 and is projected to reach $807.89 million by 2027, growing at a CAGR of 10.5% for the forecast period. The market is primarily driven by the efforts of governments and non-governmental organizations to reduce the rate of severe acute malnutrition. Moreover, changing trends and growing developments related to diet-related deficiencies, as well as increasing incidences of famine and disasters, are likely to fuel the growth of the RUTF market in the near future, according to the report.

    Management Team

    Michael Withrow is the founder, chairman and CEO of AREV. He is a successful natural products and technology entrepreneur with more than 25 years of experience. He has started and sold companies and has worked with companies such as CAVA Health Care (formerly Alternative Extracts Inc.), North American BioExtracts Inc., and Canadian Pacific Phytoplankton Ltd. He has also served as president and CEO of a specialty cannabis technology company.

    Kevin Phelps, CPA, is a director at AREV. He is CEO and president of Immune Therapeutics Inc., a bio-pharmaceutical company. He began his career with Price Waterhouse before joining Eastman Kodak Company as part of an executive team that successfully spun out the Bio Products Division into Genencor International Inc., an international industrial bio-chemicals company. He later joined Trillium Group, a regional private equity firm, as a partner, where he served on behalf of the firm as CFO of Vaccinex Inc., a vaccine development company, and chairman of AccuMed Inc., a medical device company. He has served as Chairman of Oyagen, a biotech that over the past decade has developed drug discovery methods that have enabled it to explore vulnerabilities in HIV, Ebola and coronaviruses.

    Denby Greenslade is corporate secretary and interim CFO at AREV. She has served as corporate secretary and director for several companies in the mining, biotech and IT industries and has more than 15 years of corporate secretarial, corporate governance, and securities regulation experience. She graduated from Simon Fraser University with a Bachelor of Arts in Communication.

    Allan Echino is a director at AREV. He was a founder and director of Corlac Resources, an oil producer, and Calroc Industries, an oil service company based in Alberta. Mr. Echino arranged funding for a licensed producer in the cannabis sector and quickly learned the business and health benefits of cannabis and mushrooms.

    Mel Maxwell is a director at AREV. During his 40-plus year career, he has founded six companies. His degrees in business and computer science initially took his career toward IT ventures that entailed software development, IT consulting, e-commerce solutions, real estate development, pathogen remediation solutions and wholesale vehicle aggregation. He finds continued enjoyment in consulting with other businesses and entrepreneurs.

    Scientific Advisory Board

    Roscoe M. Moore, Jr., DVM, MPH, PhD, a former United States Assistant Surgeon General, provides strategic planning for AREV’s nutritional and drug discovery platforms as chairman of the company’s scientific advisory board. Dr. Moore is a member of the board of advisers of the Institute of Human Virology (IHV) and the board of directors of the Global Virus Network associated with IHV, University of Maryland Medical Center. IHV is the first research institute in the U.S. to link basic science, population studies, and clinical trials in an effort to develop new vaccines and treatments; its 80 faculty members contribute to research on pandemic pathogens, ranging from COVID-19 to HIV.

    Dr. Moore served with the United States Department of Health and Human Services (HHS) and was responsible, for the last 12 years of his career, for global development support within the Office of the Secretary, HHS, with primary emphasis on implementing innovations in essential health care commodity procurement programs for resource-challenged countries. Dr. Moore was a career officer within the Commissioned Corps of the United States Public Health Service, entering with the U.S. National Institutes of Health (NIH) and rising to the rank of Rear Admiral. Dr. Moore worked at the Center for Veterinary Medicine, U.S. Food and Drug Administration (FDA), before becoming senior epidemiologist within the National Institute for Occupational Safety and Health of the U.S. Centers for Disease Control and Prevention (CDC), where he also served as an epidemic intelligence service officer.

    Robert Melamede, PhD, received his doctorate in molecular genetics and biochemistry from the University of the City of New York Graduate Center, focusing on base excision repair of free radical damages in DNA. For decades, he led laboratory efforts in a world-class, federally funded lab, where he discovered endonuclease VIII. Dr. Melamede did a sabbatical at the Scripps Institute and subsequently established an in vitro monoclonal antibody facility at the University of Vermont, developing antibodies to free radical damages in DNA and to DNA repair enzymes. Working with a collaborator, Dr. Melamede worked on metabolism and cancer cells as a professor and chair of the biology department at the University of Colorado at Colorado Springs. He co-founded Cannabis Science Inc., a public company, retiring as the company’s chief executive in 2014. Dr. Melamede continues his innovative research in the private sector.

    Harold Smith, PhD, is the founder, CEO, and president of Oyagen Inc., a biotechnology company developing therapeutics for various disease states, including HIV and cancer. Dr. Smith is also a tenured professor of biochemistry and biophysics at the University of Rochester, School of Dentistry and Medicine, with additional appointments as a professor in genetics and pathology and as a member of the Center for RNA Biology.

    Richard Van Breemen, PhD, is a Professor of Medicinal Chemistry in the Department of Pharmaceutical Sciences of the College of Pharmacy at Oregon State University. His research interests include cancer prevention by dietary antioxidants and prostate cancer prevention by the carotenoid lycopene, mass spectrometry-based pharmacological screening of natural products and combinatorial libraries for drug discovery, and high throughput screening to assess drug metabolism, toxicity and bioavailability. Dr. Van Breemen made The Analytical Scientist’s Power List in 2020 and 2021. His work in biomedical mass spectrometry earned him an initial spot, and he clocked in the Top 100 analytical scientists from around the world on the Power List in 2021.

    Dr. Blake Hawley is the founder & CEO of Motega Health Inc. Dr. Hawley has worked in animal health, pharma and food across 23 countries and four continents. He holds an MBA from KU and his doctorate in veterinary medicine and zoology degrees from NC State. He serves on multiple non-profit advisory boards, including the KU MBA Advisory Board. Dr. Hawley is a 2017 graduate of Pipeline Entrepreneurs and a graduate of the Village Capital Agricultural 2016 Entrepreneur Cohort.

    Dr. Hawley previously served as the General Manager of Australasia; Regional General Manager of Russia and Central Eastern Europe (consisting of 22 countries); and Managing Director of the United Kingdom and Ireland for Hill’s Pet Nutrition, a division of Colgate-Palmolive. His experience includes 10 years of profit and loss responsibilities in these territories, with consistent double-digit annual revenue growth in each of the 10 years. He oversaw products competing in the arthritis, dermatology, obesity, gastrointestinal, urinary, and cancer markets, among others. Dr. Hawley also has background in e-commerce, data analytics, and social media and most recently served as Worldwide Director of Global Digital for Hill’s Pet Nutrition.

    Uma Dhanabalan, MD, MPH, FAAFP, MRO, CMS, advises AREV on product development and formulation. She is the founder and CEO of Global Health & Hygiene Solutions LLC, whose mission is to promote wellness and prevent illness locally and globally and runs an independent practice at Uplifting Health & Wellness in Cambridge, Massachusetts. Dr. Dhanabalan, a fellow of the American Academy of Family Physicians, graduated from UMDNJ, Newark, New Jersey, with her medical degree and trained in family medicine at MUSC in Charleston, South Carolina; she earned her master’s degree in public health from Harvard’s School of Public Health in Boston, Massachusetts, and continued her training at Harvard in occupational and environmental medicine.

    Special IP Advisor

    Douglas Sorroco practices in all areas of intellectual property law including patent, trademark, copyright, technology, and e-commerce and assists clients with intellectual property matters requiring litigation, licensing, technology counselling and complex transactions.

    Mr. Sorroco is ranked in Band 1 (the top band) for intellectual property law by the highly regarded Chambers USA: America’s Leading Lawyers for Business 2021, and he was selected for inclusion in The Best Lawyers in America® 2022 for Litigation – Intellectual Property, Litigation – Patent, Patent Law and Technology Law. In 2021, Best Lawyers named him the Oklahoma Lawyer of the Year for Technology Law. In 2021, Managing Intellectual Property continued to rank Doug as an IP Star. Mr. Sorroco was selected for inclusion in Oklahoma Super Lawyers 2021 and was also selected by attorney peers for inclusion in Oklahoma Super Lawyers – Rising Stars Edition (2010).

    AREV Life Sciences Global Corp. (OTC: AREVF), closed Thursday's trading session at $0.1555, even for the day, on  volume. The average volume for the last 3 months is 82 and the stock's 52-week low/high is $0.0655/$0.32616.

    Recent News

    Nowigence Inc.

    The QualityStocks Daily Newsletter would like to spotlight Nowigence Inc.

    Nowigence has developed an impressive solution that makes sense of thousands of searches and answers processed by Google as well as accumulated data. “Its cloud-based app Pluaris automates reading and analysis of textual data, allowing users to learn more in less time and stay on top of information that is important to them, both at the office and at home. Pluaris uncovers hidden insights and enables the sharing and distribution of information in narrative-intensive documents instantaneously from various data sources, both public and private. The platform also annotates data, identifying who, what, where, when, why, how, and how much; categorizes and tags; discovers connections; and even conducts sentiment analysis. In addition, a user can enable notetaking with a single click, and Pluaris allows for collaboration between teams and enterprises,” a recent article reads. “The Pluaris platform generates a trove of critical information to assist individuals, teams and organizations to quickly build expertise. It speedily reads and analyzes hundreds of pages, and the data is transformed, linked, taxonomized, and optimized for storage and further trend analysis.” To view the full article, visit https://ibn.fm/TUIWM

    Nowigence Inc. is a fast-growing SaaS (Software-as-a-Service) company that develops and sells a ready-to-use artificial intelligence (AI) platform called Pluaris™ that automates reading and analysis of textual data. Individuals, teams, and enterprises can now quickly distill knowledge buried in narrative-intensive documents instantaneously from various data sources, both public and private.

    Pluaris is created for those who want to read more in less time. It is a Personal Knowledge Management (PKM) tool that generates an annotated data feed based on your topics of interest and automatically creates a permanent personal knowledge base from your feed and private uploads. It has human-like capabilities for comprehending textual data. It summarizes, provides precise answers to questions asked, analyzes different data perspectives, discovers new connections, creates organized nested notes, and allows teams to work collaboratively by sharing in real-time from anywhere in the world to draw informed conclusions.

    By integrating state-of-the-art data processing techniques in an intuitive interface at an affordable subscription price, Nowigence puts the power of data science in the hands of consumers. It helps individuals, teams, and organizations to quickly build expertise on one or multiple topics by generating a trove of critical information.

    Nowigence targets two user types that rely heavily on fast and accurate research as primary adopters of the Pluaris platform. The first is knowledge workers of all kinds – anyone whose job is to “think for a living” like marketing professionals, researchers, legal professionals, academics, journalists, editors, scientists, and other professionals. The second are individual users who are life-long learners, hobbyists, and enthusiasts of all stripes.

    Rather than spending time reading information to gain knowledge from one source at a time, users of Pluaris can gain knowledge from hundreds or thousands of sources in seconds. Keyword-based search-and-retrieval applications don’t open documents, nor read their content, nor extract key points, conduct cause and effect analysis or answer questions specifically. Pluaris includes all those features and goes one step further, with its semantic capabilities to empower users with interpretations of retrieved information. Nowigence estimates this feature alone can save typical researchers between one and three hours per workday. The platform also reduces “noise” by extracting only important and relevant information on every topic being monitored or researched. This helps cut down on information overload, a major source of workplace stress.

    Pluaris Builds Intelligence

    The Problem

    In the modern world, virtually everyone needs to consume a tremendous amount of text-based information, in both our personal and professional lives, but doing so is exceptionally challenging because of:

    • Information Overload: For virtually any significant topic of interest, the amount of textual information available and continually generated is vastly more than can be consumed by an individual.
    • Pervasive Distractions: Thanks to modern technology, we are constantly bombarded with new inputs (e-mails, instant messages, social media, and more) reducing our attention span, leading all too often to TL;DR (Too Long, Didn’t Read).
    • Highly Imperfect Human Recall: The information that we do find time to read is easily forgotten. Even if we retain some of the key insights, the details are almost certainly lost.

    Even when working in teams, we often end up researching the same content as our colleagues, and too much of the information acquired by one individual is lost in translation with the communication process to others.

    Pluaris

    Nowigence has worked with stalwarts and pioneers in the fields of Machine Learning (ML) and Natural Language Processing (NLP) from its early days. The company was keen to solve the big problem of the information age – too much data exists and cannot be processed manually.

    Pluaris is designed to be used by regular people from day one with no need for extensive training. The platform is used across different functions and sectors, adapting to clients’ ever-changing needs. Its state-of-the-art no code editing gives organizations the flexibility to improve and tailor their results without hiring data scientists, and real time information retrieval ensures the client never misses any piece of intelligence.

    Pluaris adapts to the unique needs by which individuals absorb knowledge. It doesn’t impose structured or rigid methodology. Real time operation means that Pluaris will deliver outputs instantaneously with a click.

    A Nowigence team of experts spent three years training Pluaris to understand the context of every sentence it reads. If Pluaris does make an error in contextual interpretation, the user can correct it, which will instantly give the correction precedence over the ML’s algorithmic outputs. This takes away the biggest criticism against AI/ML platforms, that annotating (labeling) data and developing training datasets to build models takes too much time and effort from internal teams.

    Use Cases

    I need to stay on top of the latest news for my industry. Pluaris automatically retrieves and analyzes news on your topics of interest every day, so you can quickly scroll through an annotated news feed on your phone, tablet or laptop, while finishing your morning coffee.

    Example: A Pluaris enterprise customer was interested in tracking news and events in the telecom industry. Nowigence was able to quickly create and then fine-tune a list of topics to monitor. In less than a week, they had an annotated news feed covering the telecom industry available to their team.

    I have to come up to speed on a new topic as quickly as possible. Upload a few related websites and documents to Pluaris and within minutes you are exploring this new area of interest, scanning the summaries, gaining new insights about this topic, and finding new keywords to broaden your search and deepen your understanding.

    Example: A customer who was already using Pluaris for business intelligence decided to use his account to make improvements in his health after he received a report from his doctor of a high fasting blood sugar level.

    • He uploaded a few research reports to Pluaris, read through the summaries, and explored the annotated labels. Based on that analysis, he set up Pluaris to monitor topics such as “lowering fasting blood sugar” and “low glycemic food.”
    • From those results, he built an action list of daily habits for diet and fitness and, within a couple months, brought his fasting blood sugar level back down.

    I want to be able to access the information I’ve read in the past and synthesize it with my current understanding. As you continue to add more and more information to the system over time, Pluaris never forgets. You are building a knowledge base of the information that is most relevant to you.

    Example: A Pluaris user at one of the world’s largest aluminum mining companies was tasked with preparing talking points for her manager for an upcoming investor meeting. Over time using Pluaris, she had built a database of documents, including transcripts, notes, Q&A sessions, speeches, annual reports, and internal documents, some of which were from previous investor meetings. She was able to quickly explore that database through the Pluaris Dashboard and using various filters. She then pulled this information together in a Pluaris Notebook and shared that note directly with her boss.

    Market Outlook

    Pluaris users include:

    • Knowledge WorkersGartner estimates there are more than 1 billion worldwide as of December 2019.
    • Students in Higher Education: ICEF estimates there are 250 million worldwide as of 2020. This is Nowigence’s initial target group from a market penetration perspective.
    • Personal/Home Use: Statista estimates there are 4.7 billion active internet users worldwide as of January 2021.

    Nowigence offers tiered pricing, starting at $10/month/user for individuals, while team and enterprise users, who have access to more features to facilitate collaboration and integrations to other enterprise tools, start at $45/month/user.

    As a result, the Total Available Market (TAM) is more than a billion users and over $1 trillion. The Market Opportunity (the Serviceable Obtainable Market or SOM) for Nowigence is $11 billion in the combined PKM and Cognitive Computing space defined by Pluaris.

    This market is growing rapidly too. The Cognitive Computing market alone was valued at $8.87 billion in 2018 and is projected to reach a value of $87.39 billion by 2026, growing at a CAGR of 31.6% from 2019 to 2026, according to Allied Market Research.

    Nowigence offers differentiated value compared to other Personal Knowledge Management (PKM) tools, which have reached as many as 250 million users (Evernote) and have shown rapid adoption (Roam Research reached 60,000 users and $1 million ARR within 6 weeks of launching paid plans). Unlike Pluaris, these tools do not automatically monitor public or private sources to add to your knowledge base, nor do they provide summaries or extract intelligence. Pluaris differs from search engines as well, in that search engines do not access or store personal knowledge, and they also do not summarize or extract intelligence.

    Management Team

    Anoop Bhatia is the founder and CEO of Nowigence Inc., where he has worked full-time since 2015. Previously, he worked as a global operation strategic transformation leader for Momentive Performance Material (formerly GE Silicones). He has worked for over two decades in various General Electric companies across different countries, including the U.S., India, The Netherlands and Germany. He played a key role in establishing GE Silicones as the first-ever wholly owned foreign subsidiary established in India in 1996. He received his Bachelor of Engineering in Chemical Engineering from BITS in India and did his post-graduate studies in management from Heriot-Watt at Edinburgh in Scotland.

    Gordon Haupt is the Chief Technology Officer at Nowigence. He has more than 20 years of experience building and leading diverse engineering and operations teams, and a strong technical background in machine learning, signal processing, and statistical data analysis, including applications in speech and text, biotechnology, and computer vision. He is a named inventor on 15 issued patents and is experienced in all phases of engineering development and operations. He holds a B.S. degree in Engineering Mechanics from the University of Wisconsin and M.S. and Ph.D. degrees from Stanford University in Aeronautics and Astronautics.

    David Evans is the company’s acting CFO & General Counsel. As an attorney and licensed CPA in the state of New York, he has extensive experience in multistate and international tax policies and guidelines, federal taxation laws, mergers and acquisitions, including valuation of closely held businesses. He is a contributing author to the New York State Tax Service, a six-volume publication of NYS tax laws and regulations. His prior experience includes being a Managing Director for UHY Advisors LLC, a board member and chairperson of the Tax Division Executive Committee of New York State Society of Certified Public Accountants and a past president of the Estate Planning Council of Eastern New York. He holds degrees from Hofstra University and State University of New York at Buffalo.


    Recent News

    chart

    SPYR Inc. (OTCQB: SPYR)

    The QualityStocks Daily Newsletter would like to spotlight SPYR Inc. (OTCQB: SPYR).

    SPYR (OTCQB: SPYR) is a technology company that, through its subsidiary, Applied Magix Inc., develops and resells Apple(R)-ecosystem-compatible products oriented toward the smart home and connected car spaces. The company is evaluating opportunities to expand its reach to Latin America, Central Europe and Thailand to grant its products a global market. “These are markets that need to be considered for future expansion, and we may as well start investigating a foundation now, with an eye toward the future. Applied Magix’s research and investigative efforts in this direction will help SPYR gain a worldwide footprint and potentially reach many more customers,” a recent article quotes SPYR CEO Tim Matula as saying. The company has been working to grow shareholder value through a number of product upgrades, sales and marketing efforts, recently announcing the launch of its new development initiative to upgrade MagixDrive (a wireless adapter between iPhones and vehicle CarPlay infotainment systems), and that it is preparing to develop other CarPlay products. “We are constantly upgrading our product pipeline, and our efforts to streamline our inventory benefit our tech-enthusiastic customers by making aggressive discounts available to them during our Summer Sales events,” Applied Magix CEO Harald Zink said. To view the full article, visit https://ibn.fm/tzjEE

    SPYR Inc. (OTCQB: SPYR), dba SPYR Technologies, is a technology company which, through its Applied MagiX Inc. subsidiary, develops and resells Apple®-ecosystem-compatible products with an emphasis on the growing, multibillion-dollar Internet of Things (IoT) Smart Home and Connected Car markets.

    SPYR continues to identify and target acquisitions with an aim of growing its footprint in the industry and expanding the products it offers consumers, including companies developing artificial intelligence and smart-technology products. In 2020, SPYR acquired Applied MagiX Inc., a registered Apple developer and reseller of Apple ecosystem compatible products with an emphasis on the smart home market, as a wholly owned subsidiary. Applied MagiX operates in the IoT market and, more specifically, the segment of the market related to the development, manufacture and sale of devices and accessories specifically built on Apple’s HomeKit® framework. These products work within the Apple HomeKit ecosystem and are exclusive to the Apple market and its consumers.

    Initially, while working to develop, manufacture and sell its own line of branded products, Applied MagiX will be sourcing HomeKit products and accessories from worldwide manufacturers, vetting and selecting best-of-breed products, selling them directly to consumers and supporting them. The company focuses on Apple consumers – a target market with higher disposable income and a demonstrated willingness to pay a premium for quality products. On average, Apple product users spend roughly twice as much on technology as other smartphone users. Those who purchase smart home products spend more than $3,000 on average.

    By creating smart hardware and software solutions exclusively for Apple consumers, SPYR addresses a problem faced by that market – having few “smart” devices that integrate with Apple’s HomeKit, despite being the most affluent and loyal consumers of tech products.

    Products

    The company’s Applied MagiX subsidiary offers multiple product lines to its target markets. First, the subsidiary is a reseller of third-party manufactured Apple HomeKit and Apple CarPlay compatible products. HomeKit comes pre-installed on every new iPhone, while the CarPlay platform is licensed by all major auto manufacturers. Applied MagiX identifies white label products, applies the company’s branding, improves the software and sells these improved products to consumers. Finally, Applied MagiX is developing its own proprietary line of smart home and connected car products, including Apple-compatible home cameras, sensors and alarms, as well as additional Apple-compatible smart car products in the iOS ecosystem.

    Among the subsidiary’s products sold to consumers are:

    • The MagixDrive Wireless CarPlay adapter, which allows users to access CarPlay wirelessly using their iPhones
    • The HomeKit Secure Video Camera with iCloud Storage
    • The Multipurpose Sensor with Alarm
    • The Environment and Motion Sensor
    • The Window and Door Contact Sensor

    Market Outlook

    According to Statista, the global smart home market is expected to generate revenue of more than $104 billion in 2021. The market is forecast to hit more than $187 billion in revenue by 2025, recording a CAGR of 15.75 percent.

    The number of active households in the worldwide smart home market is expected to reach nearly 500 million by 2025. Household penetration is just over 12 percent in 2021 and is projected to nearly double by 2025 to more than 22 percent.

    Allied Market Research valued the global connected car market at more than $63 billion in 2019 and projected a CAGR of 17.1 percent, which would push revenue to more than $225 billion by 2027. Allied identified rising consumer demand for connectivity solutions, surging need for constant connectivity, increasing dependency on technology and an upsurge in tech-savvy population as key factors driving the projected growth of the connected car market.

    Management Team

    James R. Thompson is the CEO, President and General Counsel of SPYR. Over the past 28 years, Mr. Thompson has deftly managed a colorful spectrum of legal clients and situations. In the process, he has helped many companies – both large and small – thrive. Now he welcomes the challenge to take the company and his career in an entirely new direction. A native of Philadelphia, he holds a J.D. from Rutgers University and a Bachelor of Science from the University of Denver.

    Jennifer Duettra is the Executive Vice President of SPYR. She brings a great deal of knowledge in mobile gaming and pop culture to the company. She is an attorney and was thrilled by the prospect to combine her law experience with a chance to be creative. She is a native of Colorado and received her Bachelor of Arts in Political Science and Speech Communication from Colorado State University. She holds a J.D. from Harvard University.

    Trang Nguyen is the CFO of SPYR. From 2019 to 2020, she served as the Financial Reporting Manager for Del Taco, where she was responsible for the preparation and filing of periodic financial reports with the U.S. Securities and Exchange Commission. From 2016 through 2019, Ms. Nguyen was Accounting Manager for Pinnacle Tax Accounting in Los Angeles, California. She was a part of Ernst & Young’s audit team in Los Angeles from 2006 to 2008, leading engagements on interim and year-end ad SOX 404 auditing procedures for major enterprise accounts. Ms. Nguyen holds a Bachelor of Art, Business Economics (Minor in Accounting) from the University of California, Los Angeles. She is a certified public accountant with an inactive license.

    Dr. Harald Zink is the CEO, Founder and Chief Product Architect of SPYR subsidiary Applied MagiX. Prior to founding Applied MagiX, he was Director of Technologies and later Vice President of Technologies at Sarkissian Productions in Los Angeles. He also served as Director of Technologies at SMZ Technologies and, for more than 17 years, as Macintosh Technology Consultant to The Walt Disney Studios in Burbank, California. He speaks five languages and holds degrees from the University of California, Riverside.

    Kelly Clark is the COO of Applied MagiX. Before joining the subsidiary, he worked as Vice President of Sales Operations at TruClear Global. Prior to that, Mr. Clark was Senior Director of Program Management at Pacific Group Ventures and Operations Manager at Barco. He has also held operations management positions at Deluxe Digital Studios and Sony Pictures Entertainment. Mr. Clark holds a bachelor’s degree in international business from the University of Southern California.

    SPYR Inc. (OTCQB: SPYR), closed Thursday's trading session at $0.0367, off by 12.8266%, on 961,771 volume. The average volume for the last 3 months is 961,771 and the stock's 52-week low/high is $0.02355/$0.1049.

    Recent News

    Kaival Brands Innovations Group Inc. (KAVL)

    The QualityStocks Daily Newsletter would like to spotlight Kaival Brands Innovations Group Inc. (KAVL).

    Kaival Brands Innovations Group Inc. (NASDAQ: KAVL) is a company focused on growing and incubating innovative and profitable products into mature and dominant brands in their respective markets. Its vision is to develop internally, acquire, own or exclusively distribute these innovative products and grow each into dominant market-share brands with superior quality and recognizable innovation. In line with this vision, Kaival Brands is the exclusive global distributor of all products manufactured by Bidi Vapor LLC, which are intended exclusively for adults 21 and over.

    Kaival Brands is on a mission to set the highest standard and elevate the adult consumer experience for vaping. The company is headquartered in Grant, Florida.

    Bidi® Stick

    Bidi® Stick, Bidi Vapor LLC’s primary offering, is the fastest-growing closed system disposable electronic nicotine delivery system (ENDS) in the U.S.

    Intended exclusively for adults 21 and over, the one-time use device is designed with premium features, including a high-quality battery, satisfying Class A nicotine offering consistently smooth throat hits and an aluminum body. Bidi Stick is ready to use straight from the package, providing a consistent and precise amount of nicotine with every draw.

    Bidi Stick and all Bidi Vapor products are sold primarily through national convenience stores, as well as online exclusively through authorized direct retailers and GoPuff, the digital convenience store.

    Bidi® Cares Initiative

    The tamper-resistant Bidi Stick is the only ENDS on the market with an ecologically friendly, mass-recycling program. The Bidi® Cares initiative focuses on promoting sustainable practices to save the environment, one step at a time, through proper disposal of vapor products.

    Through Bidi Cares, Kaival Brands and Bidi Vapor aim to promote and educate consumers on the dangers of improper waste disposal.

    Bidi® Pouch

    On January 26, 2021, Kaival Brands took a step toward building on the success of Bidi Vapor’s e-cigarette device when it announced the debut of the Bidi® Pouch. Officially launching in early February, the Bidi Pouch provides a tobacco-free nicotine formulation packed in an easy-to-go tin can, available in six flavors.

    “We are excited that Bidi Vapor continues to develop and innovate new ways to bring the Bidi Vapor experience to adult consumers. Bidi Vapor’s new Bidi Pouch offering, which we will exclusively distribute, is just another example of our ability to meet the demands of the marketplace,” Niraj Patel, CEO of Kaival Brands, stated in the news release. “The pouch marketplace is yet another opportunity to demonstrate Bidi Vapor’s premium experience to adult users. We believe that Bidi Vapor’s share of the nicotine pouch market will rival Bidi Vapor’s market share achievement in vape. It represents a significant opportunity for us as the exclusive distributor of Bidi Vapor’s products in 2021 and beyond.”

    Recent Corporate Developments

    • March 1, 2021: Kaival Brands announced its entry into two new distribution agreements boosting the company’s potential store count for Bidi Vapor products to over 54,000 – a 500% increase over 2020. Patel noted in the news release that this milestone, along with recent corporate developments, has the company “feeling extremely confident about [its] fiscal year 2021 revenue guidance range of $400m – $450 million.”
    • March 16, 2021: The company reported $37.4 million in revenue for the fiscal quarter ended January 31, 2021. This figure brought its cumulative revenues since commencing business operations in March 2020 to roughly $100 million, despite revenue slowdowns during the fourth quarter of 2020 as a result of packaging and labeling updates. Patel forecast an increase to revenues during Kaival Brands’ second fiscal quarter ending April 31, 2021. He also reaffirmed the company’s confidence in its fiscal 2021 revenue guidance.
    • March 18, 2021: Kaival Brands announced its appointment of three new directors to its board ahead of its proposed uplisting to the Nasdaq Capital Market. The appointments of Paul Reuter, Carolyn Hanigan and Roger Brooks as independent directors are intended to ensure the company complies with certain Nasdaq corporate governance rules.
    • March 31, 2021: The company announced that Bidi Vapor LLC has successfully completed the regulatory process to enter four new, significant markets – the U.K., Australia, New Zealand and Russia.

    Market Outlook

    The U.S. e-cigarette and vape market was valued at $6.09 billion in 2020, according to data from Grand View Research. The firm expects the industry to expand at a compound annual growth rate of 27.3% from 2021 to 2028, with growth factors including rising awareness of tobacco alternatives.

    Management Team

    Nirajkumar Patel is the CEO, CFO, President, Treasurer and Director of Kaival Brands and owner of Bidi Vapor LLC. In 2004, Patel received a Bachelor of Science in pharmaceutical sciences from AISSMS College of Pharmacy in Pune, India. He moved to the United States in 2005, and he continued his education at the Florida Institute of Technology, where he graduated in 2009 with a master’s degree in medicinal and pharmaceutical chemistry. He currently holds a Six Sigma Black Belt Certification.

    Eric Mosser is the COO, Secretary and Director of Kaival Brands. Mosser attended Arizona State University, where he studied business management. In 2004, he graduated from Rio Salado College with an associate degree in applied science in computer technology.

    Paul Reuter is a Director of Kaival Brands. He brings to the company nearly five decades of industry experience in small box retail as a journalist, editorial director, entrepreneur and speaker. Mr. Reuter has launched two successful businesses, including MidWest Retail Group LLC, which was the largest U.S. 7-Eleven franchise group, where he served as Chairman and founding partner from April 2013 through June 2019. He is also the founder of Kreative Collaborations LLC, an industry consultancy.

    Carolyn Hanigan is a Director of Kaival Brands. She served as the President of Reynolds American Innovation Company, an operating company of Reynolds American Inc. (“RAI”), from January 2016 to June 2018. Ms. Hanigan also led the global vapor collaboration with British American Tobacco (“BAT”) up until RAI was acquired by BAT in 2017. She served as the architect of RAI’s U.S. reduced risk products strategic direction to further the vision of transforming tobacco, preparing the U.S. commercial execution and regulatory applications for a wide array of products, including the Glo tobacco heating products; the Velo nicotine pouches; and the Alto, Ciro, Vibe and Solo nicotine vaporizers. Ms. Hanigan holds a Bachelor’s degree in business from Boston College and a Master of Business Administration degree from St. Mary’s College.

    Roger Brooks is a Director of Kaival Brands. Since 2005, he has served as the Chairman, Treasurer and Co-Founder of Abierto Networks. Prior to his roles with Abierto, Mr. Brooks was the lead independent director and a member of the compensation and audit committees for Moldflow Corporation, a Nasdaq-listed software firm that was sold to Autodesk Inc. in 2008. He holds a Bachelor of Arts degree from the University of Connecticut and a Master of Business Administration degree from New York University, Stern Graduate Business School. He is also a graduate of the Stanford University Executive Management Program.

    Kaival Brands Innovations Group Inc. (KAVL), closed Thursday's trading session at $0.955, up 2.6882%, on 263,948 volume. The average volume for the last 3 months is 263,948 and the stock's 52-week low/high is $0.52/$17.00.

    Recent News

    Prime Harvest Inc.

    The QualityStocks Daily Newsletter would like to spotlight Prime Harvest Inc.

    Prime Harvest Inc., based in San Diego, California, is a technology-focused, full-service cannabis company with horizontally diversified operations spanning various segments of the cannabis value chain, from licensing acquisition and compliance management to direct-to-consumer operations. The company is leveraging a long-term strategy of investing in the growth and scale of licensed assets anchored by the power of data-driven technology to expand its footprint throughout California.

    Sustainability is key to Prime Harvest’s corporate vision. The company aims to ensure that the communities it serves capture their fair share of the fruits of the industry’s growth, including financial profit, employment opportunities, environmental enrichment and impactful innovation through R&D and education.

    The company’s mission is to appeal to the ethos of the cannabis consumer by setting a new operational standard emphasizing accountability, sustainability and community. With this commitment, Prime Harvest continues to work toward positively affecting millions of lives through the creation of a world-class platform that caters to strengthening the commercial cannabis pipeline.

    Jaxx Cannabis

    Jaxx Cannabis is the flagship brand in Prime Harvest’s portfolio. Through Jaxx Cannabis, the company aims to use technology to facilitate a true customer-centric culture while enhancing the overall craft cannabis experience. Jaxx features an expertly curated selection of premium products from some of the most respected brands in the thriving California market.

    Key values serving as the foundation of Jaxx Cannabis include:

    • Creating and nurturing a welcoming culture for all
    • Unlocking the true potential of customer value
    • Being innovative in uncovering new ways to grow both the company and the industry
    • Meeting the wants and needs of consumers to promote profitability
    • Remaining accountable for the results of its operations

    It is these values that differentiate Prime Harvest and Jaxx Cannabis in the California cannabis sector.

    Brand Partnerships

    Prime Harvest works diligently to establish strong alliances with complementary brands that are in alignment with its culture and values. Through a combination of deliberate foresight and strategic action, the company seeks to grow existing cannabis brands and continuously discover new, high-potential performers that are primed for long-term success.

    These partnerships enhance Prime Harvest’s efforts to transform the world’s cannabis access and bring its consumers high-quality products that are fair for both people and the planet.

    Responsibility

    Prime Harvest remains committed to the goal of creating a more sustainable environment, now and in the future. Concern for human beings and the environment can be observed in every facet of its operations, including its ongoing R&D activities dedicated to exploring methods of reducing and repurposing waste into composite materials and exploring the potential of the hemp plant for industrial and wellness contributions.

    The company is a proud member of the Community Alliance Program, a foundation that seeks to make a difference in local communities by providing financial assistance for educational programs, housing homeless veterans, creating urban farms, and holding local arts initiatives for children and adults. The program also helps explore the natural healing attributes of medical cannabis through research, development, clinical trials, and advocating for the safe access of cannabis to those in need.

    Market Overview

    Ongoing changes in U.S. state government policies toward cannabis are expected to cause demand for legal marijuana to surge. In addition, the number of indications for which medical marijuana is prescribed continues to increase. These factors are expected to rapidly boost legal sales of cannabis products.

    Legal sales across the U.S. hit a record of $17.5 billion in 2020, marking an increase of 46% over 2019, according to Forbes. This strong growth is expected to continue. According to a Grand View Research report, the global legal marijuana market is forecast to grow at a CAGR of 26.7 percent from 2021 to 2028.

    California – Prime Harvest’s home state – has consistently led the pack in terms of U.S. cannabis sales. The Motley Fool pegged cannabis spending in the Golden State at $3.8 billion in 2020, more than doubling the second state on its list.

    Leadership Team

    The Prime Harvest team is composed of true experts in their respective fields focused on building a world-class organization capable of driving the cannabis industry and movement forward.

    E. Duane Alexander is the company’s Founder and CEO. He brings to the team more than 25 years of real-world, hands-on cannabis retail, marketing and commercial operations experience. Mr. Alexander has championed 40+ cannabis license applications throughout the western U.S. to date.

    John Wilczak is the COO of Prime Harvest. He has 30+ years of executive management, strategy development & configuration experience with GE, pharmaceutical and agriculture companies. Mr. Wilczak is a Brown & Columbia MBA with vast knowledge of technology driven intellectual properties.

    Andrea Jenson is the Chief Financial Officer of Prime Harvest. As CFO, she is responsible for all the company’s financial functions, including accounting, corporate finance and investor relations. Her career spans more than 20 years of varied experience in financial management, business leadership and financial strategy.

    John Kazanjian is the VP of Business Development of Prime Harvest. He has worked over 40 years in business operations, brand marketing, sales and investor/lender communications. Mr. Kazanjian earned his B.S. from Rutgers University and his MBA from Harvard University.

    Johann Balbuena is the Chief Marketing Officer of Prime Harvest. She has more than six years of experience in California cannabis licensing acquisition and compliance management. Ms. Balbuena has led multimedia production and content marketing efforts for the likes of the Social Club TV app, The Emerald Cup, High Times, Weedmaps and Synergy.


    Recent News

    chart

    American Cannabis Partners

    The QualityStocks Daily Newsletter would like to spotlight American Cannabis Partners.

    American Cannabis Partners (ACP) is a multi-state cannabis company with 560,000 square feet of licensed canopy space for cultivation and one retail license. The company is nationally headquartered in Trinity County of Northern California’s Emerald Triangle.

    ACP is focused on three complementary business segments: real estate, acquisition & development of proprietary assets, and ongoing cultivation operations. Led by a seasoned management team with 30+ years of canna-business experience, ACP’s strategy is to capture opportunities in real estate and licensing in states that have recently passed cannabis legalization legislation, thereby equipping the company to capitalize on Federal interstate commerce opportunities.

    Through its current cultivation operations, ACP supplies approximately 80% of its whole flower products for manufacturing, distribution and retail licenses. With the remaining 20%, the company supplies its proprietary strains to select California distributors and its own Michigan retail location under its exclusive in-house brand, ZÜK.

    History of American Cannabis Partners

    In 2014, Stephen Jordan, President of ACP, took on the Director of Operations position for a U.S.-based company operating in the Jamaican cannabis space. Over the course of his three-year tenure in this role, Jordan developed a number of relationships that would help serve as the basis of American Cannabis Partners.

    One such relationship was with Junior Gordon, a cultivation lead grower from Jamaica’s Westmoreland Parish. Jordan immediately saw the value of Gordon’s unique skillset and credentials, and Gordon recognized Jordan’s heartfelt vision of bringing Jamaican culture to the rapidly developing U.S. cannabis space.

    Guided by that mission, ACP’s unchanging goal is to improve the lives of individuals through cannabis and business.

    Current Operations

    Since its founding in 2018, privately-owned American Cannabis Partners has established a foothold in two key U.S. cannabis markets – California and Michigan. In total, the company has acquired 12 cannabis licenses, including 20,000 sq. ft. of cultivation licenses in California and 540,000 sq. ft. of cultivation licenses & one retail license in Michigan.

    ACP’s IP portfolio features three proprietary strains sold exclusively through the company’s wholly owned ZÜK brand, as well as proprietary data collection and mining systems supporting its cultivation and retail operations.

    Plans for Expansion

    American Cannabis Partners is pursuing additional growth in the cannabis sector through multiple planned initiatives. These include:

    • Submitting applications for additional cultivation licenses at the company’s Trinity County, California, location;
    • Planning land acquisition and project development strategies for expanding operations to its third U.S. state beginning in the second quarter of 2022; and
    • Planning land acquisition and project development strategies for expanding operations to its fourth U.S. state beginning in the second quarter of 2024.

    ACP is currently exploring expansion opportunities through partnerships and joint ventures in New Jersey, New York, Virginia, Nevada, Arizona, Missouri and Massachusetts.

    Management Team

    Stephen Jordan is the CEO of American Cannabis Partners. He is focused on the first and last steps of legal cannabis – cultivation and retail. To date, Mr. Jordan has provided the company with ownership of 12 licenses, three proprietary cannabis strains and multiple real estate assets. His background in cannabis operations and financial strategies has guided American Cannabis Partners’ efforts to produce consistently high-quality product for both the medical and recreational segments. Mr. Jordan has operated under cultivation, manufacturing, distribution, medical research (Univ. of West Indies), retail and exportation licenses in multiple countries, further strengthening his network within the cannabis industry.

    Gary Coltek is the company’s Chief Operating Officer. He has credentials based in the culinary, hospitality and sustainability industries spanning over 40 years, including taking three companies public. Mr. Coltek has held management positions internationally with Ritz Carlton, Four Seasons, Trump Hospitality, Phymatrix and International Oncology Network. For 17 years, he was the founding member and partner of a private boutique consulting firm. He is currently a guest speaker and visiting professor at universities in Israel, China, Italy, the Netherlands and Peru, covering topics that include culinary sustainability, sustainable cannabis farming, organic sustainable farming and cannabis clinical studies.

    Scot C. Crow is the Lead Corporate Counsel for American Cannabis Partners. He has extensive experience in corporate mergers & acquisitions and tax law. His clients rely on him to advise them with respect to their complex financial transactions and provide outside general counsel. Mr. Crow provides his clients proactive advice with respect to sensitive management matters, litigation management, day to day transactional needs and objective assessments for the development of successful business strategies. His experience includes serving as lead counsel for numerous mergers & acquisitions, private equity investments, private offerings, venture capital financings, mezzanine debt offerings, divestures and other related transactions, with an emphasis in the legalized marijuana segment.

    Jacob Frenkel is the company’s Lead Compliance Counsel. He is the current Chair of Dickinson Wright’s Government Investigations and Securities Enforcement Practice. Mr. Frenkel’s solutions-minded approach to issues has earned him a reputation as an aggressive, tenacious, creative and proactive defense lawyer and litigator. After 14 years as a Senior Counsel in the SEC’s Division of Enforcement, U.S. federal criminal prosecutor and New Orleans Assistant District Attorney, Mr. Frenkel has practiced in the private sector for 20 years. His unique mix of corporate transactional, litigation and investigations defense clients extend well beyond the cannabis industry and cover a wide range of industries worldwide.

    Junior Gordon is the Director of Cultivation for American Cannabis Partners. With 30 years of international cannabis cultivation experience in both the Caribbean and United States, Mr. Gordon is recognized as one of the top growers in the world. His skills span both controlled indoor and large volume outdoor harvest programs, giving him proficiency in nursery, propagation and indoor & outdoor grow strategies. As a winner of High Times and other notable Cannabis Cups, his focus is on connecting the dots between propagation, soil, irrigation, planting, harvesting, curing, processing and inventory control, bringing Jamaican cannabis cultivation best practices to American Cannabis Partners’ operations.

    Recent News

    chart

    The QualityStocks Numbers Report

    By The Numbers Chart

    Top Performers


    The QualityStocks Sponsored News


    The QualityStocks DailyNetwork Sponsors

    CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

    ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

    About The QualityStocks Daily

    The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

    Why do we spotlight companies for Free?
    We Want To bring our subscribers the top movers in an unbiased setting.

    "Homework Eliminates Mistakes"
    Please never invest in a company anyone profiles unless you do the proper research and due diligence.

    QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

    Please consult the QualityStocks Market Basics Section on our site.

    The QualityStocks Numbers Report

    By The Numbers Chart

    Top Performers


    QualityStocksTwits

    QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

    Visit Portal


    The QualityStocks Sponsored News


    The QualityStocks DailyNetwork Sponsors

    CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

    ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

    About The QualityStocks Daily

    The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

    Why do we spotlight companies for Free?
    We Want To bring our subscribers the top movers in an unbiased setting.

    "Homework Eliminates Mistakes"
    Please never invest in a company anyone profiles unless you do the proper research and due diligence.

    QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

    Please consult the QualityStocks Market Basics Section on our site.

    The QualityStocks Numbers Report

    By The Numbers Chart

    Top Performers


    QualityStocksTwits

    QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

    Visit Portal


    The QualityStocks Sponsored News


    The QualityStocks DailyNetwork Sponsors

    CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

    ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

    About The QualityStocks Daily

    The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

    Why do we spotlight companies for Free?
    We Want To bring our subscribers the top movers in an unbiased setting.

    "Homework Eliminates Mistakes"
    Please never invest in a company anyone profiles unless you do the proper research and due diligence.

    QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

    Please consult the QualityStocks Market Basics Section on our site.